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Abstract

DESIGN, SYNTHESIS, AND EVALUATION OF DITERPENONES AS POTENT
CHEMOPREVENTIVE AGENTS FOR AFB1 INDUCED CARCINOGENISIS IN
HUMAN LIVER CELLS
By Miguel A. Zuniga, Ph.D.
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor
of Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2007
Major Director: Qibing Zhou, Ph.D
Assistant Professor Department of Chemistry

Terpene quinone methides (TPQMs) have been isolated from a variety of plants
and show broad activities against bacteria, fungi, and cancerous cell lines. The biological
activity has been attributed to the reactive electrophilic QM moiety, this structural feature
has long been recognized as an intermediate in organic synthesis and in certain
biosynthetic processes. It has been shown that quinone methide structures play a key role
in the chemistry of several classes of antibiotic drugs and antitumor compounds such as
mitomycin C and anthracyclines. The goal of this study was to understand the basis of QM
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bioactivity so that terpene catechols as analogs of natural TPQMs precursors can be
designed as effective chemopreventive agents.
In order to investigate the oxidation pathway of terpene QM precursors, a
homoconjugated diterpene catechol was synthesized. A review of the literature revealed
that Cu2+ -induced oxidation of simple catechols proceeds through a two-step one electron
transfer process, and o-quinone is the sole oxidation product. In contrast, our studies
showed direct p-QM formation from a diterpene catechol and no o-quinone oxidation
products were observed. Furthermore, the Cu2+-induced oxidation pathway of our
homoconjugated diterpene catechol revealed multiple p-QM formations under aqueous
conditions. The implications of these findings suggest that terpene QM precursors can
cause extensive DNA damage through in situ generated hydroxyl radicals or by DNA
alkylations with p-QMs.
To elucidate the Cu2+-induced DNA damage mechanism, a series of catechol
analogues of natural terpene QM precursors were designed to investigate potential effects
of stereochemistry, substitutiional, and functional groups on nucleobase alkylation and
production of reactive oxygen species. The results of these tests suggested that production
of ROS was the dominant mechanism for the observed DNA damage in the Cu2+-induced
oxidation regardless of stereo and structural differences of catechols or subsequent
oxidation products as QM or quinone. From the DNA damage study we found that the
presence of NADH significantly enhanced the extent of DNA damage by oxidation of
these catechols. More specifically, in the case of alkene catechols, our results showed that
DNA damage was independent of the concentration of catechols, thus providing ample
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evidence for production of ROS through the redox cycle of catechols/quinones. Additional
support for the formation of hydroxyl radical and futile redox cycling was clearly
demonstrated by comparison of the fragmentation pattern with that of a Fenton reaction.
The identify of the ROS was also shown to be in the form of a Cu(I)OOH complex by
radical scavenging and metal chelation experiments.
Cis-terpenones were first shown to have chemoprotective activity by Dr. Zhou and
colleagues. In collaboration with their efforts to identify the mode of action of cisterpenones, another project to achieve an isotope labeled cis-terpenone was undertaken.
The isotope study was employed to obtain and experimentally demonstrate the feasibility
of incorporating a radioactive label in cis-terpenone for the future studies of cis-terpenone
metabolism. An analysis of the deuterium labeled cis-terpenone from the isotope exchange
reaction showed that the isotope was being incorporated into multiple positions through
scattering processes. This non-radioactive isotope study made it possible to optimize the
conditions prior to using a radioactive tritium label, which will be a requisite for future
metabolic studies.
As an extension of this work, a structure activity relationship (SARs) study was
undertaken with a focus on improving the physiochemical properties and chemical stability
of cis-terpenones. The primary purpose of this study was to attempt to explain the reason
for the observed protective effects of cis-terpenones against AFB1. Considerable efforts
were made to introduce an unsaturated double bond in the structure of cis-terpenone by an
intramolecular Pd (II) catalyzed Heck reaction. Unfortunately, this method was
unsuccessful and which was attributed to the disconnection of our starting material during
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the formation of an enolate intermediate. A second model study to generate desired
coumarin and ditepene related structures was investigated with a Diels Alder [4+2]
cycloaddition reaction. After numerous attempts, we found that the successfull synthesis
of these compounds was highly dependent on the temperature, solvent, and the use of
stabilizers in the reaction.
Finally, the targeted diterpene analogs were screened for protective effects against
AFB1 by the MTT cell viability assay. However, these preliminary data showed that
additional structural features and key modifications are still required to better correlate the
structure with the mechanism of chemoprotection.

1

Chapter 1
Cancer chemoprevention
1.1 Background and significance.
The term of “cancer chemoprevention” was first coined by Sporn et al, in 1976,
which he defined as a strategy for cancer control through administration of synthetic or
natural compounds capable of halting or inhibiting the onset of carcinogenesis.1,2 Sporn
contended that the process of carcinogenesis had the potential to be controlled
physiologically and pharmacologically during its preneoplastic stages, in which he
suggested that the promotion phase could be stabilized, arrested, and reversed.2,3 To date,
most cancer chemoprevention research is based on the concept of multistage
carcinogenesis, which includes cancer initiation, promotion, and progression stages. The
promotion stage has been determined from animal studies to require a longer time to
develop than both initiation and progression. This prolonged time is due to complex
cellular mechanisms and protein synthesis that are necessary from the onset of cancer
initiation to reach the point of tumor proliferation and progression.4-6 It is generally agreed
that unlike initiation and progression which are irreversible stages, cancer promotion can
be a reversible stage, and thus is likely to be a valid target for cancer chemoprevention.6-7
Most chemopreventive agents act in two ways: they can prevent genetic mutations
that lead to cancer and/or they can prevent and stop excessive replication of mutated cells.
A variety of approaches have been considered in the prevention of carcinogenesis. These
approaches include the inhibition of pro-carcinogen activation, the enhancement of cellular
detoxification pathways, the interception of carcinogenic reactive products, and the
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alteration of cellular signaling pathways.7,8 Natural products have attracted considerable
scientific interest in chemoprevention. This interest stems from the fact that many natural
products possess biological activity with high selectivity and specificity, making them less
prone to cause serious toxicity.9-11 Results from animal studies have demonstrated that
certain chemopreventive agents can induce apoptosis in tumor cells in vivo. For example,
treatment with oral infusions of polyphenolic extracts in a mouse model for prostate cancer
was found to promote a significant inhibition of prostate cancer development and increased
overall survival.12,13 In addition, the understanding of the carcinogenic process will lead to
more effective chemopreventive agents.
In this chapter, a review of Aflatoxin B1 (AFB1) and the mechanisms by which it
exerts its carcinogenic effect will be presented, and experimental studies with natural and
semi-synthetic compounds having protective properties against AFB1 will be discussed.
This is followed by a generalized intervention strategy against AFB1 by utilizing quinone
methide (QM) analog as a model for rational development of novel chemopreventive
agents.

1.2 Aflatoxin B1 as a potent procarcinogen
Aflatoxin B1 (AFB1) is a fungal metabolite that is produced by Aspergillus flavus
and contaminates food such as corn, nuts, and cereals in many areas of the world. Because
AFB1 has been detected in a variety of crops, it has been reported as a major
procarcinogen for human health risk.14,15 In 2002, it was classified by the World Health
Organization (WHO) as a class one carcinogen, because the potency and epidemiological
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evidence suggested that it is an important factor in the etiology of human liver cancers.16,17
Bioactivation of AFB1 occurs through metabolic activation by phase one cytochrome P450
(CYP) enzymes to two metabolites AFB1 exo- 8,9-epoxide and endo-8,9-epoxide. The
AFB1 exo-8,9-epoxide is highly reactive and subsequently alkylates DNA nucleobases
such as N7 of guanine and thus exerting its carcinogenic effect (Scheme 1.1).17-20 In
contrast, the AFB1 endo-8,9-epoxide only forms low levels of adducts upon reaction with
DNA because nucleophilic attack by guanine N7 is blocked by the oxirane ring upon its
intercalation into DNA.20-22

Scheme 1.1 Biotransformation of AFB1 by CYP450
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In the study by Corriea et.al,23 the structure function relationships of CYP 450 and
AFB1 were investigated. Their studies used P450 3A4 and 3A5 which are identical at
84% of their primary sequence to compare the active site differences and determine
whether these differences could influence substrate binding and regioselectivity in AFB1
metabolism. Based on their computer modeling studies, it was suggested that P450 3A4
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cannot accommodate AFB1 in an orientation conducive for its endo 8-9 oxidation while
exo-8,9 oxidation can occur due to AFB1 bound in an orientation leading to its oxidation
and stabilization with protein residues.23 In contrast, the AFB1 furan moiety was found to
bound through interaction with several regions of the somewhat more flexible P450 3A5
active site thereby favoring the exo-8-9 oxidation.23
Model studies performed by Essigmann et.al24 suggested that exo-8,9-epoxide
intercalates between DNA bases more efficiently than endo isomer, and that exo-8,9epoxide is in a favorable position for SN2 attack by the N7 guanine of DNA nucleobases
(Figure 1.1).

Figure 1.1. Intercalation of exo-8,9-epoxide and position for Sn2 attack by N7 guanine of
DNA (Essigman et. al., 2001).

5
Harris and coworkers25 have examined the reactivity of both exo and endo aflatoxin
B1 epoxide toward hydrolysis in a phosphate buffer (pH 7.0) at 23 ºC. They found have
that endo 8,9-epoxide is at least 40-fold more stable than the exo-8,9-epoxide toward
hydrolysis.25 However, the reactivity of the exo-8,9-epoxide is at least 103 times greater
with DNA than the isomeric endo-8,9-epoxide.26,27 This finding was attributed to a tight
association between the aflatoxin molecule and the nucleobases, of which covalent bonds
subsequently formed.28-30 In contrast, the endo conformation precludes the insertion of the
endo isomer within the DNA duplex. Of interest is that DNA intercalating molecules
prefer to interact with double stranded DNA, due to the favorable thermodynamic gains
through π-π base pair stacking and hydrophobic interactions.30
Raney and coworkers31 suggested that exo-8,9-epoxide adduct formation was
promoted through the specific orientation of bound epoxide, which intercalates on the 5’
face of the guanine residue in double stranded DNA. They studied AFB1 analogs with
modified ring systems and found that a decrease in planarity resulted in reduced
intercalation ability.31 For instance, a change from the planar comarin moiety and
cyclopentenone ring system to the more puckered δ-lactone ring reduced the binding of
aflatoxins to DNA.31 This situation is known to exist with aflatoxin G1, which has a
decreased planarity and affinity for DNA, resulting in lower cytotoxicity. Furthermore,
addition of the intercalating agent ethidium bromide to target DNA prior to the treatment
with AFB1 epoxide greatly reduced guanine alkylation by AFB1 epoxide.32
The reactivity of AFB1 exo-8,9 epoxide is also influenced directly by the proton
concentration and plays a major role in the hydrolysis mechanism. Guengrich and
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coworkers33 investigated the rate of AFB1 exo-8,9 epoxide hydrolysis at various pH
ranges. The half life of AFB1 exo-8,9 epoxide hydrolysis in aqueous buffer (pH 7.1) at
25ºC was found to be only ~1 s making it one of the most biologically relevant
epoxides.33,34 They found that the reaction rate of 2.3 x 103 M-1 s-1 increases linearly
below (pH 5), indicating the predominance of an acid-catalyzed mechanism for hydrolysis
in this range.33 At the higher pH values (7-9), the hemiacetal ring opens at the furan rings,
resulting in phenoxy anions and aldehydes in equilibrium with diols.33 On the basis of stop
flow kinetic studies, Guengerich et. al35 demonstrated that covalent binding of the AFB1
exo-8,9-epoxide forming the DNA-intercalated adduct occurred at a rate of k ≈ 0.2 s−1 due
to the acid catalysis.35 From these studies, it was also implied that an acidic
microenvironment around the surface of DNA molecules36,37 is also involved in acid
catalysis of the AFB1-N7 guanine alkylation. All of these results clearly indicate that
AFB1 reactivity is highly sensitive to a large pH range and is also influenced by both
electronic and structural conformations of the coumarin ring systems.
Evidence for the mutational spectrum of AFB1 has shown a prevalence of one
genetic change: GC→TA transversion, even though there is a varied distribution of DNA
adducts formed in cells when treated with this toxin. This mutation has been studied in
several experimental systems including the endogenous lacI gene in an SOS-induced
Escherichia coli strain, which contains the mucAB mutagenesis enhancing operon.38,39
Cerutti and coworkers40,41 used restriction fragment PCR to investigate mutagenic
effects of microsome activated AFB1 at codons 247-250 of the p53 gene in HepG2 cells.
Their results suggested that AFB1 preferentially induced the transversion of G→T in the
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third position of codon 249, resulting in replacement of arginine by serine. In addition,
other G→T and C→A transversions into adjacent codons were observed, albeit at lower
frequencies.40 The G→T transversion was found to be in agreement with the mutational
specificity of AFB1 and other carcinogenis that form bulky DNA adducts.42
The nucleotide excision repair enzymes (NER) in mammalian systems have been
shown to play an important role in the repair of AFB1-induced DNA damage. For
example, studies by Essigman et,al43 showed that fibroblasts deficient in the xerodoma
pigmentosum group A gene (XPA) responsible for NER showed a slower loss of AFB1N7-Gua and accumulation of formamidopyridine adducts (AFB1-FAPY) compared to
normal liver cells, suggesting that NER is an important mechanism for enzymatic repair of
AFB1-DNA adducts.43 While repair of AFB1-DNA adducts in bacteria is relatively well
understood, further research is needed to fully characterize mammalian repair of these
adducts.
Over the past 20 years, accumulated work carried out in several laboratories has
provided useful insights into the mechanism of AFB1 biotransformation and have
encouraged others to explore new chemoprevention strategies aimed at blocking AFB1
biotransformation or inhibiting the enzymes that activate this procarcinogen in vivo. In the
following discussion, examples of two chemopreventive agents used in clinical studies will
be discussed. This is followed by several examples of natural compounds which are
currently being evaluated as alternative chemopreventive agents.
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1.3 Oltipraz and chlorophyllins as chemopreventive agents against AFB1
Oltipraz was investigated as a chemopreventive agent during the 1970-1980s on the
basis that it is a facile synthesized natural product analog, and that it was already
undergoing clinical trials as an antischistosomal agent.44 Detoxification of AFB1 has been
found to involve phase two enzymes such as glutathione S-transferases (GSTs) which
promote the conjugation of gluthathione to the carcinogenic species, aflatoxin-8,9-epoxide,
thereby diminishing DNA adduct formation by a mercapturic acid adduct (AFB-NAC)
(Scheme 1.2)45,46 Studies by Langouet et.al46reported twofold to fourfold elevations in the
levels of µ and α glutathione S-transferases (GSTs) proteins in primary cultures of human
hepatocytes when treated with a single dose of 500 mg /m2 oltipaz at a concentration
comparable to that in plasma of humans.47
In a chemoprevention study conducted by Groopman and coworkers48 nucleic acid
adduct AFB- N7-Gua and albumin adducts were used as biomarkers, which were detected
and quantified with immunoaffinity chromatography and liquid chromatographyelectrospray mass spectrometry.48,49 They suggested that because the primary aflatoxin
nucleic acid adduct AFB-N7-Gua was exclusively excreted in urine after its removal from
DNA and has a short biological half life, its measurement thus reflect recent exposure to
aflatoxins. While albumin adducts found in serum are also derived from the AFB1-8,9epoxide, but are thought to reflect exposures over longer periods of time, which was based
on a half life of three weeks for albumin circulated in humans.50
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Scheme 1.2

G eneral M etabolic Pathway of Aflotoxin B1 with O ltipraz treatment
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M etabolism of AFB1 and several adducts of AFB1 currently used as intermediate biomarkers of
carcinogenesis (Kensler et. al., 1999).

Enzyme kinetic studies on heterologously expressed human CYP1A2 indicate that
oltipaz is a competitive inhibitor of cytochrome P450 with an apparent inhibition constant
(Ki) of 10 µM, a pharmacologically achievable concentration in rats and humans.51
Inhibition of CYP1A2 by oltipraz results in diminished metabolism of aflatoxin to the
genotoxic 8-9-epoxide and the hydroxylated aflatoxin metabolite M1.51-54 As illustrated
in Scheme 1.2, oltipraz exerts multiple effects on the metabolism of AFB1 in people
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exposed to this potent hepatocarcinogen. Dose and schedule dependent inhibition of
cytochrome P450-dependent activation and induction of GST-mediated detoxification of
AFB1 has been observed in clinical trials. Induction of phase two enzymes has long been
supported as an important mechanism for achieving chemoprevention.55,56
Although these studies suggest that chemopreventive agents can work by changing
the metabolism of environmental carcinogens, important questions still need to be
addressed, such as whether all phase two enzymes are inducible, or whether the genes are
inducible in humans and how they contribute to chemoprevention.57 While oltipraz has
demonstrated chemopreventive effects against AFB1, it is still unclear whether it will
actually inhibit hepatocellular cancer or acts by simply delaying cancer progression.
Problems associated with oltipraz are that it causes acute gastrointestinal toxicity and can
induce estrogen responsive genes.58,59 Due to unknown and long term side affects of
oltipraz, there is a need for alternative agents that can interfere and prevent the process of
carcinogenesis and demonstrate still better activity and or less toxicity than oltipraz.
Another chemoprevention agent which has been tested as a treatment for AFB1
induced carcinogenesis is chlorophyllin (Scheme 1.3). Mechanistic studies suggest that
chlorophyllin acts as an interceptor molecule, forming tight molecular complexes with
AFB1 and thus impedes aflatoxin absorption in the liver. Kensler and Breinholt,60-62
studied the effects of the uptake of AFB1 chlorophyllin to determine whether it could alter
the uptake or block the bioavailabilty of AFB1. During their studies, levels of aflatoxin-N7
–guanine adducts in urine samples were used as biomarkers and collected, which was
spiked with 1.5 ng of aflatoxin B2 (AFB2) as an internal standard. Afterward the
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aflatoxins were eluted with methanol and then loaded onto prepartive aflatoxin specific
mAb immunoaffinity column. Aflatoxin-N7-guanine and AFB2 were quantified by
measuring the mass area of specific MS/MS daughter fragments MH+ 152.1 and 259.1
derived from the parent ions of m/z 480.1 and 315.1, respectively. The final results of
these studies suggested that chlorophyllin achieved an overall 55% reduction in urinary
levels of AFB1 metabolites compared to subjects taking a placebo.62
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Scheme 1.3 Chlorophyllin structures used in the intervention

These studies suggest that chlorophyllin is an effective intervention agent and that
it may favorably reduce the bioavailability of aflatoxins and other classes of environmental
carcinogens. Unfortunately, although chlorophyllin is marketed as an over the counter
drug (Derifil), primarily used to control body odor and to accelerate wound healing, its
main disadvantage as an AFB1 chemoprevention agent is that it has low complexing
constant, which required an excessive oral dose per day.62 Another problem associated
with chlorophyllin is due to its high water solubility; this reduces its effectiveness and
ability to distribute in critical target organs and diseased human liver cells.
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1.4 Alternative chemopreventive agents from natural products
Several dietary products have shown promise as alternative AFB1 chemopreventive
agents. One particular interesting finding is rosmarinic acid which has shown anti-oxidant,
anti-inflammatory, and antiviral activity (Scheme 1.4). This compound was investigated
by Renzulli and coworkers63 for chemopreventive activity against AFB1 induced
cytotoxicity in a human hepatoma derived cell line (Hep G2). They found that the cell
mortality upon AFB1 exposure was reduced when the cells were preincubated with 25-50
µM (Ros A) for a duration of 24 h.63
OH
OH
HO

O

HO

O
HO

O

Scheme 1.4 Rosmarinic Acid

Besides DNA base alkylation, oxidative stress has been implicated by Galvano et.
al 64 as potential mechanisms of AFB1 toxicity. Rosmarinic acid was found to
significantly reduce the amount of reactive oxygen species (ROS) in HepG2 cells (Figure
1.2), suggesting it acts as an antioxidant and possibly can scavenge for reactive oxygen
species (ROS).63 However, the mechanism is not entirely known.
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Figure 1.2. Reactive oxygen species production in HepG2 cells treated with AFB1, and cells
treated with AFB1 and Rosmarinic acid (Renzuli et.al., 2004).

Diterpenes cafestol and kahweol (Scheme 1.5) were investigated by Calvin et.al65
for chemoprotective effects against AFB1 induced genotoxicity in rat primary
hepatocytes.65 Results of western blot analysis showed that CYP2C11 and CYP3A2
expression was reduced as cafestol and kahweol were increased from 0-4 µg/mL.
Subsequent studies by the Calvin group were aimed to determine whether cafestol and
kahweol would have any significant inhibitory effect on the formation of AFB1-adducts.
Results from DNA binding studies showed a dose dependent effect on the formation of
AFB1-DNA adducts, with an increase in cafestol and kahweol concentration (0-4 µg/mL).
Furthermore, highest inhibition of AFB1-DNA binding occurred after the cells were
incubated for 48 hrs and then treated with 4 µg/mL of cafestol and kahweol65 (Figure 1.3).
The studies performed by Cavin et.al provide preliminary evidence for the protective effect
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of natural diterpenes cafestol and kahweol and their use as potential therapeutic agents for
AFB1 carcinogenesis.
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Scheme 1.5 Structures of Diterpenes isolated from coffee extracts

These studies indicate that natural products and synthetic analogs derived from
plants have useful properties for the prevention of AFB1 induced cytotoxicty. The
activities of these natural products highly depend on their chemical structure as
demonstrated by the various biological properties of compounds in carcinogenic and tumor
bioassays and by their different mechanisms of action. However, the screening strategy for
selection of more efficient chemopreventive agents has produced limited candidates. Thus,
more efficient strategies such as a “mechanistic based” approach is needed to optimize
promising drug candidates earlier in drug discovery processes.66,67
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Figure 1.3. Cafestol and Kahweol treatment resulted in a decrease in AFB1/DNA adducts
(Calvin et. al., 2004).

1.5 Biological activities of natural TPQMs and related QM structures.
One important category of natural products that have interested us as promising
chemoprevention agents against AFB1 are natural triterpene quinone methides (TPQMs).
These compounds have shown a broad spectrum of biological activities attributed to their
reactive quinone methide (QM) moiety. The QM structural element is electrophilic and
stabilized through both conjugation and electron donating functional groups.68-69 Because
the QM is polarized, nucleophilies can add readily under mild conditions at the methylene
carbon (CH2), and thus result in aromatic phenols, which is the basis for their reactivity
(Scheme 1.6).70,71 The origins of QM reactivity and selectivity are still being investigated,
but it has been shown that steric and electronic environments play a major role in their
alkylation products. This has prompted many studies pertaining to quinone methides in
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alkylation and biomolecular alkylation processes. Most recently, the reversibility of
simple ortho quinone methide (QM) generation has been investigated by Rokita’s group
toward efficient cross linking and taget-promoted alkylation.72,73
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SR
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Scheme 1.6 Electrophilic Q M moiety and subsequent nucleophilic addition

As previously mentioned, our interest in natural TPQMs is due to their broad
spectrum of biological activities. One example of a bisnortriterpene quinone methide is
isoguesterin, isolated from the root bark of Salacia madagascariensis. This compound
was shown to have potent anti-leshminal activity 94.0 ng/mL against L. donovani and L.
mexicana (Scheme 1.7).74 Unfortunately, this compound is a skin irritant and is currently
still under further investigation. Another example, leguminase a diterpene quinone
methide has been shown to have potent activity 0.19 µg/mL against yeast Candida
albicians.75 These studies clearly demonstrate how the biological activites of QMs are
affected by specific structural features. In particular, a well studied QM is that of 2,6-ditert-butyl-4-methyl phenol (BHT). This compound is converted to BHT-QM through an
enzymatic process and is toxic to liver and lung cells.76 Again, the structural features of
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this compound have been shown to be important in influencing QM reactivity and
cytotoxicity in vitro.
Although these studies demonstrate the unique biological activities of natural
TPQMs and QM compounds, it remains unclear whether analogs of natural TPQMs can be
utilized as potential therapeutic or chemopreventive agents. Thus, the long term aim of
these studies is to investigate the scope and utility of analog TPQMs as novel mechanism
based chemoprotection agents.

O

O
OH

HO

O
H

HO
Isoiguesterin
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Scheme 1.7 Polyterpene and diterpene quinone methide derivatives. BHT is a quinone methide
formed during a P450 catalyzed oxidation process.

1.6 General intervention strategy based on TPQM analogs
The risk of AFB1 cytotoxicity is attributed to the covalent DNA modification by
the exo-epoxide metabolite, resulting in liver damage and possibly hepatocellular
carcinomas. Hence, the purpose of these studies was to develop a general approach
utilizing synthetic cis-terpenone as a potent chemopreventive agent for AFB1 in human
liver cells. These compounds were investigated because experimental studies have been
reported with other compounds and have shown induction and or inhibition of important
enzymes involved in the biotransformation of AFB1. To determine whether cis-terpenone
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has any chemoprotective effect against AFB1 induced cytotoxicity, the cis-terpenone
compound was designed and has been investigated (Scheme 1.8).
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Scheme 1.8. General strategy of chemoprevention of AFB1 carcinogenesis based on model
cis-terpenone or cis-terpenone metabolites. Terpenones are designed to block
biotransformation of AFB1 by inhibiting or reducing the expression levels of CYP450s.

Our working hypothesis is that administration of cis-terpenone will influence and
have an impact on blockage of CYP450 dependent AFB1 activation. Furthermore, the
variation in AFB1 bioactivation will play a critical role toward the response of protective
mechanisms in human liver cells. Because reducing the induction of P450s is a major
challenge for chemopreventive drugs, the potential advantage of this strategy is that
CYP450 oxidative metabolism of cis-terpenone may occur specifically within AFB1
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induced carcinogenic cells. Another important advantage is that in contrast to other
chemopreventive agents such as oltipraz, which is shown to elicit a wide range of AFB1
detoxification processes, metabolism of cis-terpenone may result in an essential
intermediate that selectively targets and blocks CYP450 active sites. Most important, this
may result in an increase in chemoprevention by enhancing the duration of cis-terpenone
thereby maximizing protection against carcinogenic AFB1 exo- 8,9 epoxide formation.
The development of novel chemopreventive agents against AFB1 has been
systematically approached by screening of natural or semi-synthetic compounds of natural
origin. The research presented here has focused on several of these aspects. All of these
results have been used in the ongoing systematic development of chemopreventive agents.
However, to our knowledge there are no studies of cis-terpenones and related catechols as
chemopreventive agents. This is likely due to the possible formation of quinone methide
intermediates during the oxidative and metabolic transformation in biological systems and
the known toxicity of quinone methide alkylation. In developing a model for
chemoprevention against AFB1 based on cis-terpenone compounds, we have investigated
the reactivity of diterpenone catechols and related derivatives under an induced oxidation
process to assess their potential role and biological impact in human liver cells.
In the following chapter, direct QM formation through Cu2+ -induced oxidation of a
precursor terpene catechol was investigated. These studies aimed to elucidate the
oxidation pathway of terpene catechol, and to provide a method for generation of stable
QM for future biological studies. This is followed by studies in chapter three that will
attempt to elucidate the Cu2+ -induced DNA damage mechanism and to evaluate the
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potential impacts of diterpenone catechols on duplex DNA. In that chapter, the
relationship between the structures of catechol precursors of natural terpene QMs and their
conversion into QM or quoinone oxidative products was investigated with a series of
terpene catechols.
In chapter four, a novel method for the synthesis and characterization of isotope
labeled cis-terpenone precursor will be presented. The goal of the labeling approach was
to demonstrate the labeling position and secondly to prove the feasibility of incorporating a
tritium label for future metabolite studies. In chapter five, analogs of the promising cisterpenone chemopreventive agent were designed, synthesized, and investigated to
maximize against AFB1 toxicity. With a diverse set of cis-terpenone and diterpene
derivatives in hand, it was anticipated that structural modification and refinement of
original cis-terpenone would provide clues to the mode of action of cis-terpenone.
Finally, chapter six consists of the different analogs that were successfully
completed and a general classification of these compounds based on their partial structural
similarities. The long term aim of these studies is to develop a rational and viable research
program around the application of cis-terpenones as novel and effective chemopreventive
agents.
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Chapter 2
Synthesis of diterpene catechol and quinone methide formation by Cu2+
induced oxidation
2.1 Introduction
Numerous studies have shown broad biological activities of natural TPQMs
through the reactive QM moiety as discussed in Chapter 1.73-76 However, evaluation of
natural TPQMs as effective therapeutics has remained a challenge due to isolation of these
compounds in pure form and at room temperature, simple unsubstituted QMs can undergo
dimerization in solutions at concentrations more than 10-5 M.77,78 Because of these major
difficulties, the studies presented in this chapter were focused on designing catechol
precursors of natural TPQMs so that we could investigate their oxidative potential and
oxidation pathway under aqueous conditions. The goal was to demonstrate direct QM
formation through Cu2+ -induced oxidation of precursor terpene catechols, and to provide a
method for generation of stable QM for future biological studies.
One objective of these studies was to elucidate the oxidation pathway of terpene
catechols as different from simple catechols such as 2-hydroxyphenol. The oxidation
pathway for this simple catechol is known to proceed through a two step one electron
transfer process, producing o-quinone as the sole oxidation product.79 In contrast, the
homoconjugated terpene catechol 1 designed in our laboratory can undergo oxidation by
three different pathways. For example, either o-quinone 2 or terpene QM 3 is directly
formed in the oxidation process, or terpene QM 3 is formed through fast isomerization of
terpene o-quinone 2 (Scheme 2.1).80 In fact, the rate of isomerization of o-quinones to
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QMs has been measured with 4-allyl catechols and found to be highly dependent on palkyl substituents.81
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Scheme 2.1 Formation of different QM species through a homoconjugated catechol (Zhou et. al
2005)

The multiple oxidation pathways of our simple model terpene catechol 1 and the
fact that catechols are readily oxidized suggested that oxidation within cells will be very
likely. In this chapter, studies to determine the identity and structure of QM formation
from our unique terpene catechol precursor were undertaken. And most important, these
studies aimed to clarify the oxidation pathway of terpene QM precursors so their impact in
biological systems could be addressed.

2.2 Modeling of terpenone QM analogs
One approach is to examine the molecular structure of terpene QM analogs by
molecular modeling. Thus, models of natural terpene QMs 4 and QM analog 3 were
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achieved with AM1 (Spartan, Wavefunction, Inc., Irvine, CA) molecular modeling by Dr.
Zhou.
Terpene QM

O
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HO
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O

H

O

HO
Tingenone

4

Figure 2.1. Comparison of molecular structures of tingenone a natural TPQM 4 and a synthetic
terpene QM analog 3 using AM1 Semiempircal molecular modeling.

As can be seen in Figure 2.1, the presence of extended π conjugation results in
flattening of the rings, which is often an important feature in natural products. In addition,
the trans-fused ring systems show extended or open structure that relieves steric
interactions between angular methyl groups and ring hydrogens. Both six membered rings
in compound 3 exist in chair conformation and are in their lowest energy form. A notable
difference between synthetic analog 3 and natural TPQM 4 is that this analog is smaller
and has fewer asymmetric centers than natural TPQM.82,83 As a result, these features
simplify the synthetic process and will permit chemical modification at later stages of the
synthesis. An important observation of this analog is its structural conformation, which is
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similar to tingenone 4, a natural TPQM. This finding suggests that this analog may have a
similar mechanism of action and activity towards biomolecules.

2.3 Synthesis of first generation of diterpene analogs
Scheme 2.2. A general synthesis strategy for diterpenone catechols
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The general strategy for synthesizing the desired trans diterpene catechol is
illustrated in Scheme 2.2. The synthesis began with 3,4-dimethoxyphenyl acetic acid 5
(Scheme 2.3), which undergoes a coupling reaction with geranyl chloride at -78˚C to
afford the desired compound 6 in 89% yield. This intermediate compound contained the
desired carbon framework for the construction of the diterpene skeleton. Compound 6
then underwent an esterification reaction with EDCI and DMAP to produce 7 with the
desired isopropyl ester functionality in 76% yield.84 The importance of the isopropyl
group is that it facilitated the desired trans stereochemistry during intramolecular
cyclization of 7 into compound 8 in 61% yield (Scheme 2.3).85 The cyclization of 7 into 8
was accomplished with BF3OEt2 in nitromethane to afford diastereoisomers. These
diastereoisomers were not separated due to the later decarboxylation step, which removed
one of the asymmetric centers. After chromatographic purification of compound 8, this
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compound was hydrolyzed under reflux conditions, to furnish the free acid 9 in 96% yield
(Scheme 2.3). The cyclized free acid 9 was then decarboxylated with Pb(OAc)4 and
Cu(OAc)2, which afforded the desired cyclic alkene 10 in 51% yield. The trans isomeric
compound 10 was confirmed by 2D COSY and NOESY experiments described in the
following (Figure 2.2).
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Scheme 2.3. Synthesis of trans diterpenone
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Reagents and conditions: (a) nBuLi, -78 °C in THF. (b) geranyl chloride, -78 °C in THF. (c) EDCI,
DMAP, i-PrOH, room temp. in CH2Cl2. (d) BF3OEt2, room temp. in CH3NO2. (e) NaOH, reflux EtOH.
(f) Pb(OAc)4, Cu(OAc)2, 140°C in quinoline. (g) mCPBA, TsOH room temp. in CH2Cl2. (h) BBr3,
room temp. in CH2Cl2. (i) Ag2O, room temp. in CH3CN.
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Spectroscopic Analysis
COSY NMR is used to identify protons that are correlated through two and three
bonds apart. Bond correlations appear as off diagonal cross peaks and are used to identify
protons, which are connected throughout the molecule (Figure 2.2). We began the analysis
by determining the location of proton Hc, which is expected to have a correlation with the
alkene protons. The alkene protons are easy to identify because they are located at 5.91
and 6.45 ppm and appear as doublets due to spin spin coupling (Spectrum A). After
expanding spectrum (A), it is then possible to identify proton Hc at 2.11 ppm because this
proton is correlated with both alkene protons at 5.91 and 6.45 ppm. After identifying the
location of proton Hc at 2.11 ppm, we acquired a NOESY spectrum to identify the relative
stereochemistry at the ring junction of compound 10. The NOESY spectrum is
demonstrated in (Figure 2.3) and is used to identify protons which are normally no more
than four angstrom apart and correlated through space rather than through bonds. Analysis
of the cross peaks off the diagonal revealed that proton Hc is correlated through space with
the region containing the methyl groups at 0.96, 1.21, and 1.62 ppm. Expanding this
region and analysis revealed that proton Hc is only correlated through space with the
methyl group located at 0.96 ppm. Additional analysis of cross peaks correlating with
proton Hc revealed the absence of a through space correlation with the methyl group at ring
junction as Hf located at 1.21 ppm. These results are now sufficient to confirm that the
relative stereochemistry at the ring junction of compound 10 is a trans stereoisomer.
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Figure 2.2. COSY spectrum of compound 10 (Zhou et. al., 2005)
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Compound 10 was subjected to electrophilic addition with mCPBA to form the
intermediate epoxide, which underwent rearrangement under acidic conditions to produce
the desired ketone 11 in 45% yield (Scheme 2.3). To form the desired catechol 1, we used
0.5 mL of BBr3 in CH2Cl2 as the ether cleavage reagent because of its high reactivity and
ease of removal during the workup.86 After treatment of 11 with BBr3, the product 1 was
formed in 82% yield. One problem we encountered when purifying 1 was that it was
necessary to exclude air during the workup so that pure racemic diterpenone compound
could be isolated.
The final diterpene quinone methide 3 was obtained by stirring a solution of 1 in
CD3CN with 5 mg silver (I) oxide at room temperature for 10 min. The suspension was
then filtered through a 0.2 µm filter (Acrodisc, 13 CR, PTFE). The 1H NMR analysis of 3
showed that aromatic and benzylic proton signals had disappeared while three new signals
were observed at 6.30, 6.40 and 6.51 ppm. These observed signals were fully consistent
with p-QM formation and indicated that o-quinone was not the oxidized product.
Moreover, it is noteworthy that QMs can be distinguished from precursor catechols due to
their very bright colors, a characteristic of conjugated quinone methides.87

2.4 Analysis of TPQM alkylation
To assess the QM 3 mode of action as a DNA alkylating agent, studies with
compound 3 and deoxyguanosine (dG) under general acid conditions were undertaken.
In these reactions, a solution of QM 3 (1.5 mM) in DMSO was added to 10 mM dG and
10 mM TsOH then analyzed at 260 nm with a gradient of 10-20% acetonitrile/water in

31
triethylammonium acetate buffer pH 4.2 by HPLC. The use of TsOH (pKa -7) was based
on the fact that activation of QM through protonation has been shown to be a requirement
in some cases of QM alkylation.88 An HPLC trace of the reaction after 2 hours is shown in
Figure 2.4c. As a comparison, the control incubations of QM 3 with and without dG are
shown in Figure 2.4a and b, respectively. The broad unresolved peaks in Figure 2.4a
indicate that QM 3 readily dimerized or polymerized. The polymerization of QM 3 is
consistent with reported studies in which unsubstituted QMs readily polymerize due to the
lack of a steric contribution by hydrophobic substituents.89,90 The three peaks detected
eluting at a position different from that of QM 3 are marked by a cross in Figure 2.4c.
These peaks were collected for 1H NMR analysis but unfortunately they revealed no
structural information about the products in the reaction. Since the reactions of QMs are
greatly influenced by the medium and reaction conditions,91,92 it was felt that perhaps a
weaker Bronstead acid would polarize and stabilize QM 3, thereby reducing its tendancy to
polymerize. Thus, studies with triflouroacetic acid (pKa 0.23) or acetic acid (pKa 4.75)
were also explored, however, no adducts were found under these conditions.
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Figure 2.4 HPLC chromatogram of 1.5 mM QM 3 in DMSO incubated with 10 mM dG followed by
addition of 10 mM TsOH and incubated for 2 hours at ambient temperature detected at 260 nm. (a)
Control run with QM 3 in DMSO, (b) 1.5 mM QM 3 and 10 mM dG. (c) 1.5 mM QM 3,10 mM dG, and
1
10 mM TsOH. Peaks indicated by a cross were isolated and analyzed by H NMR.

2.5 QM formation by Cu2+ induced oxidation of diterpenone catechol 1
The reaction of terpene QM 3 and dG failed to provide any detectable dG-QM
adduct, possibly due to polymerization of the reactive QM. This led us to examine the
formation of diterpene QM 3 by homoconjugated terpene catechol 1 through Cu2+ -induced
oxidation under aqueous conditions. As previously stated, one major difference between
the Cu2+ -induced oxidation of terpene catechol 1 and that of a simple catechol is that pQM or o-quinone can form during the oxidation of terpene catechol 1.93 In order to
determine the identity of the oxidized products and the oxidation pathways, a thiol trapping
approach was needed. This approach is useful for aquiring indirect structural information
of quinones and quinone methides, since their high reactivity precludes their direct
identification.94 This study was employed by Dr. Zhou to investigate the oxidation
products of diterpenone catechol 1 in the presence of Cu2+ upon the addition of
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mercaptoethanol. In this manner, if an o-quinone or p-QM were formed in the reaction,
then two isomeric thiol adducts should be identified.93,95 On the other hand, if the rate of
isomerization of o-quinone to p-QM had occurred at a rate comparable to the thiol
addition, then four possible thiol adducts should be formed (Scheme 2.4). The formation
of o-quinone thiol adducts can be distinguished based on the site of attachment on the
aromatic ring, while p-QM thiol adducts should give two aromatic proton signals.
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Scheme 2.4 Potential Thiol Adducts of Diterpenone o-Quinone and p-QM Zhou et. al. 2005
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Figure 2.5. HPLC analysis of the thiol addition on diterpenone catechol 1 in the absence and
presence of Cu2+ at room temperature. (a) compound 1 (0.25 µM) in phosphate buffer (5.0 mM, pH
7.0) without Cu2+; (b) diterpenone QM-mercaptoethanol adduct under organic conditions; and (c)
compound 1 (0.25 mM) in phosphate buffer (5.0 mM, pH 7.0) and mercaptoethanol (0.75 mM) in
the presence of Cu2+ (1.0 mM). (Zhou. et. al. 2005).

Figure 2.5 demonstrates the progress of the thiol trapping experiment of catechol 1 as
followed by HPLC analysis. The results in Figure 2.5a can be interpreted as follows,
catechol 1 as shown by signal A in the absence of Cu2+ remains unchanged. For
comparison, Figure 2.5b shows the reaction of thiol addition to a preformed p-QM of
diterpenone catechol under organic conditions. Direct ESI-MS analysis of this fraction
revealed four mass signals at 699, 349, 287, and 271 m/z, which were assigned as the
noncovalently associated homodimer (C38H52O8S2-H+), the molecular ion M+ (349 for
C19H26O4S-H+), M-62, and M+ mercaptoethanol, respectively. Direct fragmentation of the
dimeric mass ion signal by MS/MS confirmed the noncovalently associated homodimer.
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The homodimer formation was also observed for the diterpenone catechol in the ESI-MS
analysis, thus it was concluded that the signal in Figure 2.5b at 16 min was the direct
mercaptoethanol adduct of the diterpenone p-QM. The reaction mixture in Figure 2.5c
shows a gradual loss of catechol 1 as monitored by decrease in signal A in phosphate
buffer (pH 7.0), mercaptoethanol (0.75 mM) and Cu2+ (1.0 mM). After 20 min the initial
signal B is converted into a new signal C over a period of 50 min. From the analysis of
signal C three mass signals at 695, 347 and 287m/z were identified. The molecular ion M+
(calcd as 347 for C19H24O4S-H+), suggested that the initial p-QM thiol adduct B was
further oxidized by Cu2+ under aqueous conditions and trapped intramolecularly. The
structure of the thiol adduct obtained from signal C was confirmed by chemical shifts in
both proton and carbon- 13 spectrum and illustrated in Scheme 2.5.

OH

OH
HO

HO
Cu2+

Cu2+

pH 7.0

1
HOCH2CH2SH

S

S
OH

O

12

O

O

13

Scheme 2.5 Thiol adducts of diterpenone catechol 1 in the presence of Cu2+ (Zhou et. al. 2005)

2.6 Extent of DNA damage by diterpenone catechol 1 in the presence of Cu2+
The direct mercaptoethanol thiol adduct 12 and 13 of the diterpenone catechol
implied that the oxidation pathway of terpene catechol 1 proceeds solely through p-QM
formation under aqueous conditions and may be unique for the diterpenone catechol 1 in
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the Cu2+ induced oxidation process. Furthermore, the Cu2+ - mediated oxidation of
diterpenone catechol was significant because of the implication that multiple DNA lesions
could result from the oxidative DNA damage by the hydroxyl radicals and/or nucleobase
alkylation by QMs.
To verify the extent of DNA damage with diterpenone catechol 1 in the presence of
Cu2+ -induced oxidation, a polyacrylamide gel electrophoresis (PAGE ) experiment was
performed. This experiment was accomplished by Dr. Zhou using a 30-mer
oligonucleotide as the target DNA and radiolabeled with 32P-phosphate at the 5’-position
with T4 polynucleotide kinase. In this study, the final reaction solutions contained 1.0 µM
duplex DNA, 5.0 mM phosphate buffer (pH 7.0), CuCl2 (0, 750, 0, 750, 250, 83, 150, 50,
or 17 µM) and compound 1 (0, 0, 250, 250, 250, 250, 50, 50, or 50 µM, respectively) in
10% acetonitrile. After incubating these reactions at 37 ºC for 2 h, a portion of each
reaction was then treated with formamide and separated by 20% denatured PAGE. The
piperidine treatment was achieved by mixing the reaction solution with a 10% piperidine
solution and subsequently heating at 90 ºC for 20 min. Afterward, each reaction solution
was separated by 20% denatured PAGE and analyzed by gel image analysis software.
The results of these studies are summarized in (Figure 2.6). As expected, no DNA
damage was detected with either Cu2+ or diterpenone catechol 1 alone. This indicates that
catechol 1 does not undergo auto-oxidation and consistent with our previous study (refer to
Figure 2.4a). However, in the presence of Cu2+ and compound 1, the oxidative DNA
damage was clearly non-sequence selective and in proportion to the concentration of
compound 1. Since no evidence for selectivity was detected in either single stranded
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(ssDNA) or double stranded DNA (dsDNA), this suggested that the Cu(II)-diterpenone 1
system does not specifically target structural features of the DNA strand. When the DNA
modification of ssDNA and dsDNA were compared, it was found that dsDNA is less
susceptible to oxidative lesions than ssDNA.96 These differences are most likely
influenced by their different stacking conformation and most importantly, the greater
stability of the duplex strand.
As shown in Figure 2.6 extensive DNA oxidation and base damage was observed
with compound 1 250 µM and CuCl2, thus reflecting the high toxicity on DNA by terpene
catechol 1. Upon further analysis of these assays, the non-piperidine treated samples
indicated that direct DNA cleavage was due to fragmentation of the DNA backbone by the
hydroxyl radicals. In contrast, the samples treated with piperidine suggest that cleavage of
the DNA was due to the considerable indirect nucleobase damage. However, no alkylation
products were observed as evident by the lack of a higher molecular band in the conditions
studied. Thus, it is inconclusive whether the indirect DNA nucleobase damage was due to
either the oxidation or alkylation process or combination of both.
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32P-5’-CGC

ACA GAG GAA GAG AAT CTC CGC AAG AAA
GCG TGT CTC CTT CTC TTA GAG GCG T-5’

a) No piperidine treated
ssDNA
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b) Piperidine treated
ssDNA
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Figure 2.6 PAGE analysis of the oxidative damage on DNA by diterpenone catechol 1 in the presence
of Cu2+. Each reaction solution contained 1.0 µM oligonucleotide, phosphate buffer (5.0 mM, pH 7.0),
and 10% CH3CN. Reactions were initiated by adding a solution of 1 (250 or 50 µM), and the resulting
solutions were incubated at 37 ºC for 2h. The piperdine treatment was achieved by adding a solution
of 10% piperdine, and the resulting mixtures were subsequently heated at 90 ºC for 20min. The
concentrations of Cu2+ in the lanes were as follows: 1, 0 µM; 2, 750 µM; 3, 0 µM; 4, 750 µM; 5, 250
µM; 6, 83.3 µM; 7, 150 µM; 8, 50 µM; 9, 16.7 µM; 10, 750 µM; 11, 250 µM; and 12, 83.3 µM (Zhou et.
al. 2005).

2.7 Mechanism for oxidation of diterpenone catechol 1 in the presence of Cu2+
The extensive DNA cleavage by compound 1 (250 µM) even at one-third the
concentration of CuCl2 (83 µM) was fully consistent with disproportionation of the
Cu(II)/Cu(I) redox cycle. The similar DNA fragmentation pattern implied that a common
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reactive oxygen species (possible hydroxyl radical), was produced during the oxidation
process. Support for the presence of this reactive hydroxyl radical species was attributed
to the cleavage of the DNA in a non-sequence specific manner.97 To account for the
production of this common reactive species, we proposed a mechanism for the Cu(II)diterpenone 1 catechol system. In this process, we proposed that initial oxidation of
diterpenone 1 produces p-QM through disproportionation of Cu2+/Cu+ redox cycle with
subsequent production of hydroxyl radical. This p-QM intermediate then undergoes
nucleophilic addition to form a mono adduct diterpenone catechol which generate hydroxyl
radicals and a second p-QM in the Cu2+/Cu+ redox cycle. The second p-QM then reacted
with another nucleophile to form a stable bis adduct diterpenone catechol as the final
product (Scheme 2.6).
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Scheme 2.6 Catechol oxidation and generation of hydroxyl radicals (Zhou et. al. 2005)
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The significance of this process is that a terpene QM 3 as an analog of a triterpene
QM was generated from the induced oxidation of a terpene catechol 1 under aqueous
conditions. Most importantly, we found that a second oxidation of this thiol adduct
resulted in formation of a bis-mercaptoTPQM 13 adduct. Support for the conversion of an
initial QM adduct to another QM, is the oxidation of an ammonium adduct of a natural
diterpene QM reported by Kupchan et.al.98 The fundamental novelty in our studies is that
our results suggest a unique Cu2+ induced oxidation pathway for a homoconjugated
terpenone catechol 1, which formed multiple QMs from this one compound. Furthermore,
a p-QM is generated in preference over o-quinone formation under the conditions studied.

2.8 Conclusion
The reported biological activities of triterpene quinone methides (TPQMs) has led
our investigation of the terpene catechol 1 as potential antitumor or anticancer agent. A
synthetic analog of a natural TPQM 3 was synthesized and investigated for a possible
QM-dG nucleoside adduct. Unfortunately, no adduct was observed under these
experimental conditions, possibly due to the undesirable polymerization of terpene QM 3
as side reaction. The oxidation pathway of diterpene catechol 1 as a TPQM precursor was
found to form a p-QM capable of undergoing consecutive nucleophilic additions and
further oxidation to QMs. Our analysis of the DNA damage by terpene catechol 1 in the
presence of Cu2+ induced oxidation showed extensive DNA oxidation and fragmentation of
both single stranded and double stranded DNA. The similar cleavage pattern of DNA
oxidative damage by diterpene catechol 1 in the presence of copper (II) suggests a common
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reactive species. This reactive species could be hydroxyl radicals generated in situ and
responsible for causing the non-sequence selective cleavage of the DNA. The studies in
this chapter suggest that natural terpene QMs may exist as terpene catechol prior to their
isolation or conversion by oxidative enzymes. If so, then catechol precursors may be
useful intermediates in the design of QM based drugs.
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Chapter 3
DNA modification by diterpene quinone methide analogs
3.1 Introduction
The results of our previous studies in chapter 2 demonstrated that multiple terpene
QM’s were formed from a homoconjugated catechol precursor 1 through the
disproportionation of Cu(II)/Cu(I) redox cycle (Scheme 3.1). The high reactivity of QM 3
toward nucleophiles was confirmed, and extensive DNA damage was observed during the
oxidation process.99 Because cytotoxicity of catechols has been attributed to o-quinone
formation and subsequent alkylation and/or redox cycles, the studies in this chapter are
aimed at clarifying whether DNA damage in the presence of terpene catechol is due to the
reactive QM intermediates and/or from reactive oxygen species generated from the
disproportionation of Cu(II)/(Cu(I) redox cycle (Scheme 3.1).99 Therefore, the objective of
this study was to elucidate the Cu2+ induced DNA damage mechanism and to evaluate the
potential impacts of diterpenone catechols on a short 30mer DNA oligonucleotide. To
achieve this, a series of catechols were designed to study the potential effects of stereo-,
substitutional, and functional groups on the QM formation and subsequent damage on
DNA.
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Scheme 3.1 Diterpenone Catechol 1 as a precursor for terpene QM 4 resulted in DNA damage in the
presence of Cu2+ (Zuniga et. al. 2006)

3.2 Synthesis of methyl substituted diterpenone catechol
One disadvantage of our previously synthesized terpene QM 3 was that it was
stable only in anhydrous acetonitrile at a diluted concentration, and red precipitation was
observed upon concentration due to polymerization. To overcome this, we envisioned that
a methyl substituent may contribute enough steric hindrance to prevent polymerization and
this may contribute to additional selectivity of quinone methides toward certain
nucleophiles.100 It has been pointed out by Angle and coworkers that intrinsic structural
features, such as the distortion of the quinoid ring and electronic delocalization play an
important role in lowering the reactivity of 2, 6 –disubstituted and other QMs in
comparison to unsubstituted QMs.101 Most recently, Rokita’s group demonstrated that
electron donating substituents stabilize formation of QMs and adduct distribution toward
DNA nucleosides.100,102 Therefore, to investigate the effect of a methyl substitutent on the
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QM formation, we synthesized this compound using our previously established
methods.103
In this synthetic pathway, commercially available 2,3-dimethoxytoluene 14 was
reacted with chloromethyl ethyl ether by a Friedel Craft alkylation to generate benzyl
chloride 15 in 47% yield. Afterward, nucleophilic substitution of benzyl chloride 15 by
cyanide furnished 16 in 92% yield. Subsequent hydrolysis of 16 was achieved by
refluxing in sodium hydroxide solution to produce the free acid 17 in 63% yield. The
coupling reaction of free acid 17 with geranyl chloride produced unconjugated free acid in
70% yield (structure not shown). The uncyclized free acid was converted into ester 18, by
standard esterification conditions and then cyclized to the desired methyl ester 19 in 60%
yield (Scheme 3.2). This intermediate was different from isopropyl ester 7 in our synthesis
of unmethylated diterpenone catechol 1 (refer to Scheme 2.3). For this synthetic route, we
found that the methyl ester 19 resulted in higher cyclization yield, than that of isopropyl
ester possibly due to steric effects around the aromatic ring.104 Subsequent hydrolysis of
19 resulted in 20, which was then decarboxylated to furnish the desired alkene 21 in 53%
yield. This compound was then epoxidized with mCPBA followed by rearrangement in
the presence of TFA to produce ketone 22F in 41% yield. Cleavage of the methyl ether
groups generated diterpenone catechol 23 in 54% yield (Scheme 3.2). Catechols 25 in
80% yield and 26 in 68% yield, were obtained directly from the deprotection of the alkene
intermediates 21 and 10 from the synthesis of analogues 1 and 23.
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Scheme 3.2. Synthesis of methyl substituted trans diterpenone
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Reagents and conditions: (a) chloromethylethylether, in AcOH room temp (b) 18-crown-6 ether,
KCN, in DMF at room temp (c) NaOH, reflux MeOH (d) nBuLi, -78 ºC in THF (e) geranyl chloride,
in THF (f) DCC, DMAP, MeOH, room temp. in CH2Cl2 (g) BF3OEt2, room temp. in CH3NO2. (h)
NaOH, reflux MeOH (i) Pb(OAc)4, Cu(OAc)2, 140 °C in quinoline (j) mCPBA, TFA, 0oC in CH2Cl2.
(k) BBr3, room temp. in CH2Cl2.
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3.3 Synthesis of Cis -Diterpenone
An interesting feature of natural TPQMs is that all of these compounds have trans
fused ring systems, and no natural compounds with cis fused ring systems have been
reported. Based on model studies, we found that cis-diterpenone adopts a bent
conformation that shields the carbonyl group at the rigid fused ring junction. In contrast,
trans diterpenone lies in a relatively flat conformation and exposes the carbonyl group at
the fused ring junction (Figure 3.1). The unique structural conformation of the cis-fused
system led us to synthesize cis diterpene catechols as precursor analogs of TPQMs and
evaluate their potential QM formation and the corresponding properties.

HO
HO

H
O

trans isomer 1

HO
HO

H
O

cis isomer 22

Figure 3.1. Conformational analysis of diterpenones based on AM1 molecular modeling. The cisisomer 22 adopts a unique bend structure while trans-isomer 1 is in a flat conformation. (Zuniga
et. al. 2006).
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For the synthesis of cis-diterpene catechols, the carbonyl group of commercially
available geranyl aldehyde 27 was protected with 1,3-propanedithiol to form 28 in 88%
yield. Compound 28 and previously synthesized 15a, b were then coupled with nbutylithium at -40 ºC with a dry ice and acetonitrile bath for 5 hours to form product 29a,b
and purified as a cis/trans diastereoisomeric mixture by a flash column separation (Scheme
3.3). Initial attempts to use bromide, rather than chloride of 15a,b were unsuccessful due
to the direct competition of the halogen metal exchange of the benzyl bromide. We also
found that the temperature of this reaction was critical to facilitate the formation of
lithiation of dithiol 28.105 For example, when the temperature was lowered to -78º C, the
reaction gave unsatisfactory results and a mixture of undesired products.
To remove the thiol protecting group of 29a,b we first investigated the use of
carbonate salts and HgCl2 in a mixture of methanol and water (9:1). The role of the
carbonate salts is to neutralize the mixture which becomes acidic during the deprotection.
We found that deprotection of 29a,b to form 30a,b was achieved in 50% yield with HgO
and HgCl2. Similar yields were obtained when HgCl2 was used with K2CO3, CaCO3 or
CsCO3 but the reaction was sluggish. After further investigating the reaction conditions,
we found that a higher yield could be obtained with a shorter reaction time and when
compound 29a,b was completely dissolved in methanol before the addition of water.
Cyclization of conjugated product 30a,b furnished 31a,b at room temperature with
BF3OEt2 in nitromethane (Scheme 3.3). Similar to the cyclization step of the previous
methyl ester, we observed that the yield of 31b was much higher than 31a, possibly due to
the additional methyl group. Cleavage of the methyl ethers on compound 31a,b with BBr3
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produced the desired compound 22 or 24 which were purified by a flash column
separation.

Scheme 3.3 Synthesis of methyl cis diterpenone
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Reagents and conditions: (a) HS(CH2)3SH, BF3OEt2, -50 ˚C in THF (b) nBuLi, -40 ˚C in THF (c)
HgCl2 HgO, room temp. 9:1 MeOH/H2O (d) BF3OEt2, in CH3NO2. (e) BBr3, room temp in CH2Cl2.
The yields are only representative of compound 24.

Spectroscopic analysis
The proton and carbon chemical shift assignments for the cis isomer 31a were
confirmed by 1H NMR, NOESY, and 13C NMR techniques. The 1H NMR spectrum of 31a
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showed the chemical shifts corresponding to the three methyl groups on the C-ring (refer
to Scheme 3.1) at approximately 1.02, 0.94, and 0.36 ppm. By contrast, the methyl groups
on the C-ring of trans isomers 11 and 22 occured between 1.32-0.97 ppm. The cis isomer 31a showed a large coupling constant of 23.0 Hz for the benzylic hydrogen atoms
at 3.39 ppm. This coupling constant was not observed for the previously synthesized trans
isomer 11, which showed a singlet for the benzylic hydrogen atoms at 3.55 ppm.
The stereochemistry of cis isomer 31a was confirmed by 2D NMR NOESY
analysis. The NOESY spectrum (Figure 3.2) indicates that proton He located at the ring
junction is at 2.09 ppm. Analysis of the diagonal crosspeaks indicated strong NOE signals
to the methyl groups located at 1.05 and 0.94 ppm. This suggested that proton He is
correlated through space with two angular methyl groups; this is in contrast to one
correlation observed in Spectrum D in Figure 2.3. On the basis of these NOESY
correlations, we confirm that the relative stereochemistry of compound 31a is a cis
stereoisomer.
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Figure 3.2 NOESY spectrum of analog compound 31a (Zhou et. al., 2006).
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The oxidation of cis catechol 22 with Ag2O in CDCl3 afforded analytically pure pQM 32, which was confirmed by both 1H and 13C NMR analysis (Figure 3.3). In the 1H
NMR spectrum, the signals of benzylic protons of 22 at 3.5 ppm disappeared completely
upon oxidation, while four singlets were observed between 6.20 and 6.90 ppm (Figure
3.3). The 13C NMR shown in Figure 3.3 also revealed eight carbon signals above 100
ppm as compared to seven of 22 which indicates formation of the conjugated QM. An
important finding of this work was that in contrast to the high reactivity of our previous
terpene QM 3, we found that p-QM 33 of the cis catechol 31 remained unchanged upon
concentration and storage over several weeks at -4 ºC. The remarkable stability of p-QM
33 was attributed to its unique bent conformation (refer to Figure 3.1), which may
effectively prevent polymerization upon concentration.

O

OH
HO

HO
Ag 2O
CDCl 3
22

O

H

32

O

H

Figure 3.2 NOESY spectrum of analog compound 31a (Zhou et. al., 2006).

Figure 3.3. 1H and 13C NMR spectrum of 32 showing distinguishable proton resonances and carbon
signals.
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In a similar fashion, catechol 25 was oxidized and formed selectively o-quinone 33,
which was confirmed by both 1H and 13C NMR analysis. The 1H NMR analysis showed
four proton resonances from 6.0-6.5 ppm (Figure 3.4). The two proton resonances at 6.5
ppm have a small coupling constant of 2.2 Hz and are in the characteristic alkene region.
The 13C NMR shown in Figure 3.4 revealed eight carbon signals above 100 ppm, with two
distinguishing signals at 181 and 180 ppm corresponding to the diketone. The significance
of these investigations was that these studies suggested that p-QM formations are unique to
homoconjugated catechols as the oxidation products, while o-quinones are formed
preferably for simple catechols or conjugated catechols.
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Figure 3.4. 1H and 13C NMR spectrum of 33 showing distinguishable proton resonances and carbon signals.
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3.4 DNA oxidative damage by a series of terpene catechols
As previously stated, the Cu2+- induced oxidation of diterpenone catechols was
investigated with a wide range of compounds having stereo- , substitutional, and functional
group differences as shown in Scheme 3.4. As demonstrated in earlier studies, the homoconjugated compounds 1, 22- 24 are capable of forming p-QM’s, while conjugated
compounds 25, and 26 form exclusively o-quinones from catechol compounds.106

Scheme 3.4. Catechol analogs screened in DNA damage experiments
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To examine the potential of DNA modification and the extent of DNA lesions by
diterpenone catechols, a short 30/25 mer oligonucleotide was used as the target sequence.
For the DNA damage study, reactions were initiated by mixing 0.25 µM duplex DNA, 40
µM copper (II) chloride, and catechols 1, and 21-26 at concentrations of 10-40 µM in 10%
acetonitrile and then incubated at 37°C for 12 hours. The samples were then treated with
piperidine and separated through a 20% polyacrylamide gel electrophoresis (PAGE). The
percentage of DNA damage was calculated based on the amount of the originally
radiolabeled DNA band versus the total amount of radioactive DNA determined with the
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Molecular Dynamics Typhoon 8600 Variable Mode Imager and Image Quant software
(Molecular Dynamics).
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Figure 3.5. DNA damage experiment after piperidine treatment. 40 µM Cu2+, 10-40 µM catechols
1, and 22-26, 0.25 µM DNA, 0.5 mM MgCl2, 10 mM Phosphate buffer (pH 7.40) at 37 ºC for 12 hr
treatment. The percentage was calculated as the average from three independent experiments
using the amount of undamaged radiolabeled DNA versus the total amount of radioactive DNA. The
average standard deviation was 5%. (Zuniga et. al. 2006).

The results after piperidine treatment are shown in Figure 3.5. As was expected,
neither diterpene catechols 1, and 22-26 alone nor Cu2+ at (40 µM) was able to induce
detectable DNA damage. On the other hand, the gel analysis following piperidine
treatment showed an increase in DNA fragmentation with all diterpene catechols 1, and 2226 suggesting that these compounds induced base damage (Figure 3.5). From the
piperidine treated gel assay in Figure 3.5, the results showed an increase in the percentage
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of damaged DNA with increase in concentration (10-40 µM) of all the diterpene catechols
1, and 22-26. It is clear from Figure 3.5 that the extent of DNA damage after piperidine
treatment was concentration dependent within each compound yet varied from one
another.106 The percentage of undamaged DNA by each diterpene catechol 1, and 22-26 is
quantified in the bottom of Figure 3.5. On the basis of the percentage of undamaged DNA
in (Figure 3.5), we found that trans diterpene catechols 1 and 25 caused more DNA
damage than other analogs at the same concentration. When comparing DNA damage by
alkene catechols 25 to 26, we found that 25 causes slightly more damage than 26.
Comparison of catechol 1 to 23 showed that the additional methyl group on the A-ring
decreased the amount of DNA damage significantly, and moderate decrease was observed
in the case of 25 and 26. However, this effect was not observed with cis-catechols 22 and
24, suggesting that DNA damage cannot be directly correlated with methyl substituted
diterpene catechols. Interestingly, we found that the amount of DNA damage by cis
catechol 22 was much lower than by trans catechol 1, probably due to its unique bent
conformation.106
From the gel analysis of Figure 3.5, we found that despite the different levels of
DNA damage, all the diterpene catechols 1, and 22-26 induced a similar fragmentation
pattern. For example, when compared with the same percentage of DNA damage at 30 µM
of 22, 10 µM of 1, and 20 µM of 25, almost identical patterns were observed. The
similarity in the fragment pattern indicated that DNA damage was due to a common
mechanism in the presence of Cu2+.106,107
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3.5 DNA oxidative damage in the presence of NADH and Cu2+
The above DNA studies were aimed at examining the role of stereo, substitutional,
and functional group effects on diterpene catechols in relation to their impact on DNA
damage. In related studies, Penning et al, reported that redox cycling of polyaromatic
hydrocarbon o-quinones caused three types of DNA damage in the presence of NADPH
and CuCl2.107,108 Because NADH can participate in electron transport, and function as a
one electron reductant, it has been proposed that the high redox potential of copper metal
ion can catalyze NADH autooxidation to NAD• being further oxidized to NAD+ with
generation of ROS to form active oxygen species cauing DNA damage.109 Therefore, the
purpose of this study was to clarify the role of NADH in Cu2+ induced oxidation of our
catechols and to evalutate the effects on DNA damage. Thus, we continued to investigate
the role of a reducing agent on the oxidation of our diterpene catechols with specific
attention to conjugated catechols 25 and 26.106
The DNA study was performed under similar conditions as previously described in
the DNA damage study of Figure 3.5. A major difference in this experiment was that
NADH to mimic NADPH was added and the concentration of each diterpene catechol and
copper were reduced eight and four fold, respectively. The objective of using lower
concentration of diterpene catechols is to determine whether the DNA damage is a result of
the hydroxyl radical regenerated in redox cycle and/or due to diterpene catechol. For this
study, a reaction solution with 100 µM NADH, compounds 1, and 22-26 (0.5, 1, 2, and 5
µM respectively), 0.25 µM DNA, 5 µM Cu2+ in 10% acetonitrile was incubated at 37º C for
6 hours. The samples were then treated with piperidine and separated through a 20%

57
polyacrylamide gel electrophoresis. The percentage of DNA damage was calculated based
on the amount of the originally radiolabeled DNA band versus the total amount of
radioactive DNA determined with the Molecular Dynamics Typhoon 8600 Variable Mode
Imager and Image Quant software (Molecular Dynamics).
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Figure 3.6. DNA damage experiment, with 100 µM NADH and 5 µM Cu2+ with compounds 1, 22-26 at
concentrations of 0.5-5 µM after piperdine treatment. The concentration of duplex DNA was 0.25 µM
DNA in a 10 mM Phosphate buffer (pH 7.40) and 1 mM MgCl2. The percentage was calculated using
the amount of undamaged radiolabeled DNA versus the total amount of radioactive DNA, and the
average standard deviation was 5%. All the reactions were repeated three independent times.
(Zuniga et. al. 2006).

The results after piperdine treatment are shown in Figure 3.6. Comparison of the
gel image in Figure 3.6 revealed a similar fragment pattern to that without NADH shown
in Figure 3.5. However, a major difference in this study was that more than 80% of the
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original DNA was damaged with diterpene catechols 25 and 26. As shown in Figure 3.6,
the extent of DNA damage is not concentration dependent with catechols 25 and 26, this is
demonstrated by comparing the percentage of undamaged DNA at 1 versus 5 µM of
catechols 25 and 26.106 Furthermore, DNA damage was found to be higher with transditerpenone catechols 1 and 23 than with cis-catechols 22 and 24 in a concentration
dependent manner, but the methyl effect was not apparent.
From the gel analysis of Figure 3.6, the enhanced DNA damage with NADH in the
Cu2+ induced oxidation of diterpene catechols 1 and 22-26 was attributed to the reducing
capability of NADH. For example, the concentration dependent DNA damage with
catechols 1 and 22-24 implied that NADH might reduce the oxidation products only
partially. However, the extent of DNA damage with alkene catechols 25 and 26 seemed
not concentration dependent. This suggests that alkene catechols 25 and 26 undergo
oxidation into their quinone forms and then fully reduced by NADH to the initial catechol
25 and 26, forming a complete redox cycle of catechol/quinone with Cu2+ induced
oxidation (Scheme 3.5).106 Further support for the reducing capability of NADH can be
seen in the increase in DNA damage by catechols 1 and 22-24 even at low 5 µM Cu2+
concentration, suggesting NADH may participate in the disproportionation of hydroxyl
radical generated by Cu2+ induced oxidation of catechol.
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Scheme 3.5 Redox cycle of terpene catechol/quinone through Cu2+ and NADH (Zuniga et. al. 2006)
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3.6. DNA oxidative damage vs QM alkylation damage
Our previous studies suggest that hydroxyl radicals generated during diterpenone
Cu(II)/Cu(I) redox cycles may be responsible for the observed non sequence selective
DNA damage. In order to further investigate this, we compared the cleavage of a 30-mer
oligonucleotide by diterpenone catechol 1 to that by a known non selective DNA radical
damaging system. We only selected compound 1 in this study to use as a representative
example and for comparison to a Fe(III)-EDTA system which causes non selective damage
by free hydroxyl radical, known as Fenton reaction.110,111 The Fenton sequencing analysis
involves Fe (II) salt mediated decomposition by dihydrogen peroxide, which produces
highly reactive hydroxyl free radical (Refer to balanced disproportionation reaction 1).
Furthermore, the oxidized Fe(III) is reduced back to Fe(II) in situ by ascorbic acid as the
reducing agent and EDTA prevents iron from binding to a substrate, as a result, it
accelerates hydroxyl radical formation at a low concentratrion.110
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Fe2+ + H2O2

Fe3+ +

OH + OH
(1)

Fe

3+

+ H2O2

Fe2+ +

OOH + H+

For the Fenton reaction, the reaction was inititated by freshly mixing mixing (1
mM) Fe(II)EDTA, 10 mM of ascorbic acid, 0.25 µM of DNA, with H2O2 0.1, 1, and 3 %
and the reaction were then incubated for 10 and 20 minutes, respectively. DNA damage
with (10-40 µM) of trans- diterpenone catechol 1 were performed with 40 µM Cu2+ for 12
hours. The samples were then treated with piperidine and separated through a 20%
polyacrylamide gel electrophoresis. Both gel assays were compared with their
fragmentation pattern by phosphoimage analysis with Image Quant Version 1.1 (Molecular
Dynamics).
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(a) 40 µM Cu2+ and 10 µM compound 1
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Figure 3.7. Relative DNA cleavage intensities by laser densitiometry analysis of electrophoresis
gels. Similar fragment pattern was obtained in the DNA damage by Cu2+ induced oxidation of
catechols versus that by hydroxyl radical, revealing ROS as the DNA damaging mechanism. DNA
fragment patterns were obtained with (a) 1 at 10 µM; (b) Fe3+ -EDTA and H2O2. (Zuniga et. al.
2006).

As shown in Figure 3.7, a similar DNA cleavage pattern was observed between
Cu2+ induced oxidation of diterpenone 1 and the Fe(II) EDTA Fenton reaction. The
similar cleavage pattern supported our previous hypothesis that DNA damage is formed
through in situ generated hydroxyl radicals as a non selective DNA damage.112 This DNA
fragmentation pattern is consistent with 4’-deoxyribose cleavage followed by
fragmentation of DNA backbone.113,114 These results imply that despite the initial
structural differences of catechol compounds 1, and 22-26 and their subsequent oxidation
products as QM or quinone, the dominant mechanism for DNA damage was through
production of reactive oxygen species.
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DNA damage by hydroxyl radical has been fully studied and several mechanisms
have been proposed. For example, Penning114 and coworkers suggested that degradation
of calf thymus DNA by aromatic hydrocarbon o-quinones in the presence of NADPH and
CuCl2 was attributed to DNA strand scission.114 They proposed that the DNA strand
scission is initiated by abstraction of the C-4’ proton of 2’-deoxyribose by ·OH, which
forms a peroxyl radical through the addition of molecular oxygen. In a second step,
oxidative cleavage of the C-3’-C-4’ bond yields a base propenal or 4’-keto-1’-aldehyde
abasic site which is consistent with oxidation at the 4’ position of deoxyribose (Scheme
3.5).114 This mechanism is largely accepted for the 4’ DNA strand scission by hydroxyl
radicals. However, more recent studies have reported that ·OH can add to the double bond
of the nucleic acid base followed by molecular oxygen to generate a peroxyl radical.
One common method used to identify which ROS is responsible for DNA damage
is by using ROS scavenging agents. By using specific ROS scavengers and metal
chelators, the identity and involvement of •OH can be inferred, which can then be used to
help predict the DNA damaging mechanisms.115 For example, radical scavengers such as
mannitol, DMSO, EtOH, and sodium formate are known to inhibits free hydroxyl radical
•OH.115,116 However, superoxide dismutase is a superoxide anion O2•- scavenger, while
catalase specifically quenches hydrogen peroxide H2O2. Copper (I) metal chelators are
also frequently used to detect whether Cu+ is involved in DNA damage, the typical metal
chelators are bathacuproine and catalase.
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Scheme 3.6. Proposed reaction mechanism of DNA strand scission by hydroxyl radical
produced during the reaction of PAH o-quinones, NADPH, and Cupric Chloride. Only hydroxyl
attack at C4' is indicated. Although other mechanisms of strand scission are possible, aerobic
DNA cleavage via a C-4' Criegee rearrangement is preferred. (Penning et. al. 1997).

To fully the reveal the identity of the HO• in our Cu2+ induced oxidation, we
further conducted the experiements of hydroxyl radical scavengers and metal chelators on
DNA damage by the Cu(II) diterpenone 1 system. The results of our studies are shown in
Figure 3.8, which clearly demonstrated that all of the free hydroxyl radical scavengers had
no effect on the extent of DNA damage.117 This observation is in agreement with studies
by Oikawa and coworkers which reported that DNA damage induced by 2-hydroxy
catechol was not inhibited by the free hydroxyl radical scavengers.118 However, further
analysis of Figure 3.8 shows that Cu+ specific metal chelators catalase and bathocuproine
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completely inhibited DNA damage. Also methional, a well known copper hydroperoxy
complex (Cu(I)OOH) chelator, completely blocked Cu2+-induced DNA damage. These
results suggest that a Cu(I)-hydroperoxo complex is likely responsible for the observed
DNA damage, and not the free hydroxyl radical in the Fenton reaction, although a similar
DNA fragment pattern was observed.117

Figure 3.8. The effect of radical scavenger and copper chelators on DNA damage by diterpenone
1 (20 µM) and Cu2+ (20 µM) after piperdine treatment. Concentration duplex DNA was 0.25 µM in
10mM phosphate buffer (pH 7.40) and 1 mM MgCl2. Radical scavengers and chelator
concentrations were as follows: 5% for ethanol, 0.1 M for mannitiol, 0.1 M for sodium formate, 5%
for DMSO, 1.5 unit/10 µL for superoxide dismutase, 1.5 unit/ 10 µL for catalase, 50 µM for
bathocuproine, and 0.1 M for methional, respectively. (Zuniga et. al. 2006).

3.7 Conclusion
In this chapter, we investigated DNA damage with a series of terpene catechols 1,
22-26 as analogoues of natural QM precursors and suggested that production of ROS was
the dominant mechanism for the observed DNA damage in the Cu(II)-induced oxidation.
We found that DNA damage by hydroxyl radical was non- sequence selective. Nucleobase
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cleavage occurred with all the diterpene catechols 1, and 22-26 regardless of stereo- and
structural differences. In addition, the extent of DNA damage was greater in the presence
of NADH than that without NADH, which was attributed to the reducing capability of
NADH. In the case of conjugated catechols 25 and 26, the extent of DNA damage was not
concentration dependent, suggesting that NADH was able to reduce the formed quinones
fully to the initial catechol thereby forming a complete redox cycle of catechol/quinone
with Cu2+ induced oxidation. As a result, disproportionation of Cu(II)/Cu(I) with oxygen
continuously produced ROS until all of NADH was fully depleted. These results provide a
fundamental basis for future biological studies on oxidative metabolism of terpene
catechols. This may further contribute to the understanding of natural catechols and their
ability to act as complete carcinogens.
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Chapter 4
Chemoprotection against AFB1 by cis-terpenone and isotope labeling
4.1 Introduction
The previous studies in chapter 3 demonstrated that cis-diterpene catechol 21
showed less DNA damage than alkene and trans diterpene catechols while no direct
nucleobase alkylation products were observed.119 On the other hand, the carcinogenic
effect of estradiol has been shown to undergo a metabolic process through o-hydroxylation
oxidation to quinone/QM and subsequent nucleobase alkylation.120,121 Therefore, an
analogous metabolic pathway is possible for the natural terpene QM, which can be
produced from p-hydroxylation of cis terpenone 35 and subsequent oxidation to QM as
shown in Scheme 4.1. The hypothesized hydroxylation of cis-terpenone 35 is based on
reported aromatic hydroxylation of similar compounds such as estrogens by P450 mediated
reaction.120,121
One important difference between estrogenic compounds and designed cisterpenone 35 is the unique bent conformation. This unique bent distortion has been
implicated in the interesting reactivity of cis-diterpene catechol 21 and exceptional stability
of a synthesized cis-terpene QM 32.119 Furthermore, the hypothesized hydroxylated
metabolite of 35 is identical to our chemically synthesized cis catechol 21 and partially
resembles the structure of reservatol, a potent inhibitor of P4501A/B activity.122,123 Since
the carcinogenic and acute toxic responses of AFB1 are dependent on its metabolic
activation, then one conceivable approach to reduce or block AFB1 biotransformation to
its exo-8,9 epoxide, would be to prevent its activation by CYP450 enzymes.124 As
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previously dicussed, the general intervention strategy in Chapter 1 implies that cisterpenone 35 may be a suitable substrate for CYP450 enzymes. Therefore cis-terpenones
were selected as ideal candidates to investigate for protective effects against AFBl induced
toxicity and to determine whether cis-terpenones have inhibitory potential on P4501A/B.
Scheme 4.1 Hypothesized hydroxylation of cis-terpenone based on reported estradiol metabolism
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The chemoprotection effects associated with cis-terpenones 35-37 were first
demonstrated by Dr. Zhou and colleagues using cell viability assay and other studies.125
They also reported that 35 can block the activity of CYP 1A/B induced by the carcinogen
2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD).125 In connection with their chemoprotection
studies, they used the MTT tetrazolium assay to determine effects on cell viability of cisterpenone derivatives 35-37 substituted at primarily one position of the A ring system.
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The results of this study are shown in Figure 4.1 and show that co-treatment of
2 µM AFB1 and cis-terpenones 35-37 at various concentrations (10-40 µM) resulted in a
gradual increase of cell survival with increasing concentrations of cis terpenones up to
80% at 40 µM. Furthermore, no cytotoxicity was observed by cis-terpenone alone. Also
shown in Figure 4.1, is that there is no significant change in the activity of cis-terpenones
by these various derivatives 35-37. This is demonstrated by the similar chemoprotection
and concentration-dependent effect with all three cis-terpenones 35-37 despite the
difference in chemical functionality (phenol, methyl, and ester group). Based on these
results, cis-terpenones are promising candidates for novel mechanism based preventive
agents, but futher research to understand the protective effect of cis-terpenones is needed.
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Figure 4.1 Chemoprotection with cis-terpenones against AFB1-induced cytotoxicity. HepG2
cells were co-treated with AFB1 (2 µM) and cis-terpenones 35-37 at various concentrations (1040 µM) and incubated for 72 h. Cell viability was measured with the MTT assay. The
percentage of viable cells was based on cells treated with medium only. Each bar represents
the mean +/- SD of four replicates. The data are representative of three independent
experiments. *P< 0.05 and **P < 0.001 compared to treatment with AFB1 by one way ANOVA
and Dunnett’s test. (Zhou et. al. 2006).
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4.2 Design of isotope labeled terpenone precursor
To fully investigate the mechanistic action of the cis-terpenone 35 and evaluate
how cells metabolize this compound a stable radiolabeled 35 is needed. One effective way
of radiolabeling is to incorporate an isotopic label in the structure. The ideal radioactive
tracer for the metabolic studies was tritium because it has similar chemical properties as 1H
and a high specific activity 29 Ci/mmol. A main advantage of high specific activity is that
it allows for confirmation of the related metabolites.126,127 In addition, radioactive tritium
has a relatively long half life (t1/2) of 12.5 years as compared to 32Phosphorous (t1/2 2
weeks) and decays through weak β- emission at 5 keV.128 The relatively long half life and
weak emission of tritium will minimize its handling and exposure. Based on the above
consideration, protection of laboratory personnel can be achieved by proper shielding,
wearing a lab coat, gloves, and keeping a routine wipe test. We started the synthesis of 41
containing a non-radioactive isotope to optimize the conditions for the tritium labeling of
cis-terpenone. The purpose of this model study was to first demonstrate the labeling
position and secondly to prove the feasibility of incorporating a tritium label in cisterpenone. After demonstrating successful isotope incorporation, these studies can be
extended with a radio-isotope to track the cis-terpenone metabolites and quantify the
distribution of these metabolites.
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4.3 Deuterium label model reaction
As previously stated, before preparing a tritium labeled compound, the reaction
conditions with a non-radioactive deuterium were optimized to investigate the positions of
isotopic incorporation and to minimize competing side reactions. Synthesis of deuterium
labeled 41 began by using commercially available 3-methoxybenzyl chloride 38. This
compound was coupled with previously synthesized 28 with n-butylithium at -40 ºC in dry
THF, to afford 39 in 51% yield. Deprotection of 39 with HgO and HgCl2 resulted in
formation of the conjugated ketone 40 in 54% yield (Scheme 4.2).

Scheme 4.2 Synthetic pathway of deuterium labeled terpenone
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Before the key next step, we proposed a plausible mechanism for the desired
isotope exchange reaction as illustrated in Scheme 4.3. The first step is the initial
formation of the enolate intermediate through electron donation by the methoxy group.
This intermediate undergoes a subsequent intramolecular cyclization with the electron
deficient polyene π electrons which is coordinated through an electronic interaction with

71
D2O and BF3OEt2. Coordination of D2O and BF3OEt2 promotes deuterium bond breakage,
by stabilization of the positive charge and release of HOD and BF3OEt2. One of the later
steps is the subsequent loss of hydrogen atom to reform the aromatic ring system and
desired 41 (Scheme 4.3).
Scheme 4.3 Proposed mechanism of deuterium exchange
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To test our hypothesis, we reacted 40 with 5eq DCl and 10 eq BF3OEt2. After
purification, the product was identified as starting material and there was no cyclized
product 41 formed by 1H NMR. As a result of the failure of DCl to produce the desired
cyclized product, an alternative isotopic reagent D2O, was investigated. Deuterated oxide
(D2O) was chosen as the alternative since literature data indicated that it had been
effectively used to introduce deuterium in conjugated polyene systems.129 The deuterium
incorporation was carried out with 10eq D2O and 15eq BF3OEt2 which we believed formed
our desired product 41. Based on our standard workup, we initially thought 41 to to be of
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high purity since only one major spot was observed by TLC and purification by flash
chromatography was straightforward.
Hc

36

c

A
Hb

H3CO

C
B

b
H
O

a

Ha

a. Reference sample without deuterium 36
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Figure 4.2a,b. 1H NMR spectrum of sample containing deuterium 41 and sample without
deuterium 36 dissolved in CDCl3, the chemical shift region is expanded to show only the region of
interest. Both spectra are referenced to CDCl3 signal at 7.2ppm (not shown).

At first, we investigated the incorporation of isotopic deuterium in 41 with 1H
NMR and 13C NMR analysis. The 1H NMR spectra of labeled and unlabeled samples are
shown in Figure 4.2a and b, which contain the expanded chemical shift region for the Cring of 36 without D2O and Figure 4.4b, the expected labeled product 41. By comparison
of 1H NMR spectra data, we observed little difference in splitting patterns or resonance
shift, while integration of the 1H signals was inconclusive. In the case of our 13C NMR
analysis, a triplet splitting pattern of 1:1:1 was observed in the range of 18-22 ppm. This
signal seemed to be consistent with one deuterium labeled methine (CH) in the methylene
substituent (CH2) a shown in Figure 4.3. The coupling constant was measured at 8 Hz, and
the intensity of this triplet could be rationalized as the coupling by the deuterium, (spin
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number I=1) as compared to the deuterated chloroform (CDCl3) signal. If this were a true
deuterium signal, then this indicates that around 50% deuterium was incorporated in the
product 41.
Deuterium replacement ?
H
H

H3CO

H
O

41

Figure 4.3. 13C NMR spectrum of 41 dissolved in CDCl3. The region of interest corresponds to the
expected labeled position. The triplet resonance at 18.9 ppm is due to deuterium magnetic spin
number I=1 and the coupling constant was measured at 8 Hz.

Electrospray ionization mass spectrometry was also used to investigate for the
incorporation of deuterium. In the MS spectrum of expected deuterium labeled 41 and
unlabeled 36, the [M + H]+ at 273.1776 for unlabeled 36 was not observed. Therefore,
MS/MS of m/z 310 was investigated for ions near the target compound mass. In Figure
4.4a, molecular ion species were detected in labeled sample 41 which correspond to
(M+1), (M+2), and (M+3) ion species greater than the expected mass of unlabeled 36.
Comparison of Figure 4.4a and b shows that molecular ions are of higher intensity in the
expected labeled 41, but greater sensitivity to locate the [M+H]+ of unlabeled 36 with ESIMS conditions is needed. Based on the observed mass shift units of the expected labeled
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41 in Figure 4.4a, these studies suggest that deuterium atoms were possibly incorporated in
41 in the prescence of D2O.
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Figure 4.4. ESI-MS of both expected labeled 41 and unlabled 36 dissolved in CH3OH and
fragmented in positive ion mode. The mass unit shifts and the intensity pattern of expected labeled
41 correspond to the molecular ion related peaks m/z 272, 273, and 274 show one or two unit
difference.

To further confirm the incorporation of deuterium, we conducted an additional 13C
DEPT experiment. This experiment can provide detailed analysis about the types of
substituted carbons and therefore would allow us to differentiate CH, CH2 and CH3 signals.
The merit of this study is that if deuterium were incorporated at the proposed CH2 position,
an additional CH carbon signal would be observed in the 13C DEPT experiment (Figure
4.5). Based on the chemical structure of cis-terpenone structure 36, we would expect 4
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CH2 signals if it were unlabeled and 3 CH2 signals in the DEPT experiment if deuterium
were in fact incorportated. Surprisingly, we found that the 13C DEPT experiment indicated
that the number of CH2 carbons signals remained unchanged, while several weak signals
were observed. In addition, the triplet 1:1:1 signal remained unchanged, indicating limited
deuterium was incorporated.

Figure 4.5. DEPT experiment indicating the different type of carbons containing hydrogens within
expected labeled 41. In this experiment there are 4 CH3 signals, 4CH2 signals, and 4CH signals
indicating only partial deuterium incorporation. The triplet signal at 18.9 ppm remains unaffected.

Finally, the incorporation of isotopic deuterium was fully confirmed with a 1D
deuterium NMR experiment (Figure 4.6). In this experiment, the parameters were set up
as follows: sample was dissolved in non-deuterated solvent, turned “lock off”, “lock pwr”
and “lock gain” were set at 0. A standard C13 parameter set was used but it was changed
to “lk”, in this case the lock channel was used for data collecting. The internal reference
was CDCl3 set at 7.27 ppm and any 2H reference position was redeemed as 1H position.
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in CDCl3
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in CHCl3
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CDCl3
a. CHCl3

Figure 4.6 1D NMR spectrum indicating positions of isotope incorporation. Based on the
observed resonances deuterium is incorporated in six positions of 41. The largest signal is at
1.2 ppm which corresponds to the location of the CH2 hydrogens.

In the 1D deuterium NMR analysis, the peaks observed at 6.6-6.8 ppm indicate that
deuterium is incorporated in the aromatic ring of 41, while the signal observed at 1.2 ppm
is attributed to incorporation at the desired position, and is consistent with our proposed
mechanism. Figure 4.6 also shows that the signal at 1.2 ppm is more intense with respect
to the other observed signals. This suggests that more incorporation of deuterium is
observed at 1.2 ppm. A hypothetical structure with the isotope substitution at this position
is illustrated in (Scheme 4.4).

77
D
c

D
a

b

H
O

H3CO
D

D
D

D

Scheme 4.4 Proposed isotope labeled 41

The isotope scattering in the structure observed in this study, was consistent with
scrambling of H-D exchange reported by Sajiki130,131 and coworkers using compounds
containing labile carbonyl functional groups.

4.4 Conclusion
This work established the feasibility and usefulness of incorporating an isotope
label in our cis-terpenone molecule 41. This isotope labeled compound was designed
based on our previous synthetic route and characterized by MS analysis, 13C NMR and
subsequent deuterium NMR techniques. It was shown that deuterium can be incorporated
using isotopic exchange reaction with D2O and BF3OEt2 at several positions of the
compound. As a result, these studies will allow us to use a radioisotope to monitor cisterpenone metabolic transformation and the formation of potential reactive metabolites in
human liver cells.
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Chapter 5
Synthesis of diterpene analogs for structural activity relationship study
5.1 Introduction
Although cis-terpenone 35 showed chemoprotection against the procarcinogen
AFB1 in liver cells and has low cyto-toxicity by itself, it was not clear at the current stage
why this compound has such a unique effect. In this chapter, synthesis of diterpene
analogs were undertaken to investigate the activity and clarify the chemo structures
responsible for the protective effect of cis-terpenones.132 The overall design of the
analogs was summarized in Scheme 5.1. The diterpene analogs A were designed to block
the aromatic positions on the A ring system, so that formation of potential QM/quinone
intermediates could be prevented. It was anticipated that by preventing QM formation,
competing side toxic reactions could be minimized and, as a result, only desired
chemoprotective effects would be enhanced. For the diterpene analogs B, the idea was to
incorporate substituents so that the metabolism of the parent compound could be altered.
For example, the bromo group will block the positions for the hypothesized
hydroxylation by CYP450 enzymes, which has been shown as a major toxic
pathway.132,133 Therefore, with diterpene analog B, we could examine whether certain
aromatic position is required for the protective effect of diterpenes. For diterpene analogs
C, a secondary hydroxyl group was introduced at the C ring system to increase the
solubility in the medium and/or perhaps the cellular absorption of these compounds
across lipid membranes. The fourth model was constructed based on a coumarin system
so that we could evaluate whether the benzylic hydrogens play a role in the protective
effects of diterpenes. It was also thought that the lactone ring might be a key structural
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feature in the protection; furthermore, additional functional groups on the C ring will be
evaluated (Scheme 5.1). The overall goal of these diterpene analogs was to attempt to
characterize the chemical structural features that are involved in the protective effects of
diterpenes.

Scheme 5.1 Analog Design of diterpene analogs of cis terpenone for SARs
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5.2 Synthesis of diterpene analogs for SARs
Model A
Our route for diterpene analog A began with the commercially available 3,4
dichlorobenzylic chloride 42. This compound was coupled with previously synthesized
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28 with nBuLi at -40°C to form 43 in 53% yield. Subsequent deprotection of 43 with
HgO and HgCl2 proceeded smoothly to furnish 44. Cyclization of 44 by treatment with
BF3OEt2 in nitromethane, generated a mixture of impurities and a partial cyclization
product. In an effort to produce 46, the reaction temperature was lowered and
alternative Lewis acids such as SnCl4 and/or TFA in nitromethane were used.134 After
monitoring the reaction by TLC, the structure of the major product of these reactions was
determined by 1H NMR analysis. The major product 45 was identified as an
intermediate in the reaction. Based on these results, it was suspected that the chloride
atoms are weak electron donors and therefore prohibit the formation of our desired
product 46 as shown in Scheme 5.2.
Scheme 5.2 First diterpene analog study to prohibit QM formation
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Model B
The synthesis of model B would serve two purposes: 1) it would allow us to
determine whether all the aromatic positions are required for activity, and 2) whether the
larger size of the bromide would affect the biological properties of terpenone structure.
In this study, commercially available 3-methoxybenzyl chloride 47 was first brominated
by standard conditions using 10% Br2 solution in CH2Cl2 (Scheme 5.3). As indicated by
1

H NMR analysis, this procedure was fairly consistent and generated the desired 48 with

few side products. The para position of the bromide with respect to the methoxy group
was confirmed by ROESY spectra analysis (see appendix).

Scheme 5.3 Synthesis of bromine substituted diterpenone analogs
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Reagents and conditions: (a) Br2 in CH2Cl2, 0oC. (b) nBuLi -78oC in THF. (c) HgO, HgCl2 in 9/1
MeOH:H2O. (d) BF3OEt2 in CH3NO2 at room temp. (e) BF3OEt2 in CH3NO2, 50 oC
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Coupling of 48 and 28 was achieved using n-butyllithium to form 49 in 58% yield.
Removal of the thiol group with HgO and HgCl2 in a mixture of methanol and water (9:1)
generated 50 in 45% yield. The attempted cyclization of 50 by addition of BF3OEt2 at
room temperature in nitromethane failed to generate the desired product 52. After
isolating the major side product in the reaction, analysis by 1H NMR showed that a partial
cyclization product was formed 51. Based on the structure of this side product, it was
believed that at room temperature, sterics prevent the molecule from complete cylization.
The 1H NMR of 51 is shown in Figure 5.1, and revealed three resonances in the aromatic
region which suggest that the tricyclic ring was not completed. Furthermore, the
resonance at 5.5 ppm confirmed the presence of an alkene hydrogen.

H3CO
Br

51

O

Figure 5.1. 1H NMR spectrum of 51 showing distinguishable proton resonances

On the other hand, when the temperature was elevated to 50 °C, the cyclization of
50 proceeded smoothly to give a major product 52, which we initially thought to be the
cis-isomer. However, based on 1H and 13C NMR analysis shown in Figure 5.2 two
doublets at 7.3 and 6.6 ppm with a coupling constant of 8.7 Hz corresponding to the
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aromatic hydrogen resonances where observed, while three methyl signals at 1.00, 1.24,
and 1.35 ppm confirmed 53 as a trans stereoisomer. From the 13C NMR analysis in
Figure 5.2, eight carbon signals where observed above 100 ppm with one distinctive
signal at 198 ppm corresponding to the carbonyl carbon.

H3CO

H3CO

Br

Br
H

H
O

53

O

Not 52

Figure 5.2. 1H and 13C NMR spectra of 53 showing distinguishable proton resonances and carbon
signals.

Model C
The synthesis of diterpene analog C aimed to insert a secondary hydroxyl group
into the C ring system of terpenone closely paralleled that of the previously discussed cisterpenones. Conversion of unconjugated polyene 40 into 54 proceeded smoothly by way
of treatment with mCPBA in 56% yield (Scheme 5.4).
Scheme 5.4 Attempted insertion of hydroxyl group by Analog C
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Before attempting the next key step, a possible mechanism to form the desired product 55
was proposed as shown in Scheme 5.5.
Scheme 5.5 Proposed pathway for formation of hydroxyl substituted diterpenone
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Reagants and conditons: a, mCPBA, in CH2Cl2 b. BF3OEt2 in nitromethane

In this mechanism, electron donation by the methoxy group will activate the initial
enolate. This enolate is then expected to donate its electrons to reform a carbonyl and
activate the alkene to attack the subsequent epoxide ring to form the diterpene skeleton.
Once open, the epoxide will reprotonate to form a secondary alcohol and the aromatic
system will be regenerated upon the release of hydrogen.
To test our hypothesis, compound 40 was treated with BF3OEt2 in nitromethane
and reacted for 3 hours. Upon workup of the reaction, we found that the desired product
55 was not formed. Based on 1H NMR analysis, the structure of one characterizable side
product 56 was found as five member ring ether. A mechanism for the formation of this
undesired product is illustrated in Scheme 5.6, which shows that the side product
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proceeds by the faster five member ring formation to a stable cyclic product. Attempts to
open the epoxide ring under slightly acidic conditions were unsuccessful and led us to try
a different approach for introduction of a hydroxyl group.

Scheme 5.6 Proposed competitive side reaction
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Thus, we decided to transform our previously synthesized 51 into 58 by conventional
mCPBA reaction. Interest in 57 was due to the anticipated opening of the epoxide to
form 58, a tertiary alcohol by way of a Grignard reaction.135 However, these experiments
were unsuccessful due to the sluggish formation of the Grignard and therefore not further
investigated (Scheme 5.7).

Scheme 5.7 Formation of Diterpene B model
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As an extension of this work, efforts to facilitate the introduction of a double bond
in the terpenone structure were undertaken. The idea of introducing a double bond was
twofold, first this would flatten the C ring system, and second this would increase the
lipophilic character of diterpene analogs. In these studies, we selected the Heck reaction
by which to perform the key cyclization of 50 due to its well known versatility in
constructing complex ring systems.136,137 The general mechanism for the Heck reaction
proceeds with formation of a palladium species followed by the elimination of palladium
to give an arylated alkene derivative. Thus the Heck reaction was considered to be an
effective approach to form our desired target 59.
Scheme 5.8 Studies on diterpenone formation using Heck Reaction
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To form the target compound 59, polyene 50 was reacted with Pd(OAc2)/PPh3 and
K2CO3, in DMF and then heated at 125 ºC for 12 hours. After the reaction was complete,
we found that none of the desired Heck products were formed. Attempts to modify the
Heck reaction conditions by different procedures are shown in Scheme 5.8. In these
experiments either the base or solvent, or both variables were modified, but this reaction
resulted in a complex mixture of various degradation products. In addition, a significant
quantity of 50 was recovered along with an undetermined amount of fragmentation
products. To minimize observed fragmentation of 50, different Pd(II) species and bases
were employed, but these methods also failed to provide 59. Several possible reasons for
not generating 59 could be ascribed to the unsuccessful optimization of the palladium
catalyst or the need for stoichiometric amounts of metal additives to form nucleophilic
reagents in situ.138 This led to the use of tetrabutylammonium fluoride to accelerate the
reaction, but this also was found to be ineffective. Based on the general mechanism of
the Heck reaction, it is highly possible that the initial oxidative insertion of palladium
into the arylbromide bond may be too slow and furthermore not well tolerated due to the
enolate intermediate formed by compound 50 during the Pd(O) migration step of the
reaction.

Model D
A fouth model study to design coumarin derivatives was investigated. In these
studies, an oxygen atom of a lactone ring was chosen to substitute for the benzylic
hydrogens previously occuping this position. It was felt that these oxidizable benzylic
hydrogens could possibly lead to unstable intermediates such as enols, and therefore limit
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desirable properties of diterpene structure. Thus, modification at this labile position was
expected to have a positive contribution to the activity of this new model compound. The
synthesis of coumarin derivatives began with commercially available 1,3-catechol 60
which was treated with 61 to undergo a Pechmann condensation to furnish 62 in 67%
yield (Scheme 5.9).139 This important transformation established the required lactone
ring structure without the need for additional steps. To this end, the phenol group of 62
was converted into the methyl ester 63 upon treatment with methyl iodine and K2CO3 in
54% yield as shown in Scheme 5.9.

Scheme 5.9 Formation of Diels Alder Adduct and Derivatives
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As a means to construct the desired ring structure of 65, a Diels Alder reaction
was investigated. Following the work of Vaccaro et.al140 the initial reaction conditons
for the Diels alder employed treatment of 63 with isoprene in refluxing xylene. These

89
conditions, however, were unable to affect the desired [4+2] cyclization. After further
reviewing the literature, we found that an electron withdrawing group is necessary to
facilitate dienophilicity of the coumarin double bond. Therefore, selective conditions for
the oxidation of the methyl group on the double bond of 63 with selenium dioxide were
investigated.140 From these investigations, we found that the optimal conditions for the
oxidation of 63 was when 63 was treated with selenium dioxide in xylene and then heated
at 50 ºC in a sealed vessel for a 24 hour period.
Structural confirmation of 64 was achieved by 1H NMR analysis, which showed a
single resonance near 10.2 ppm due to the aldehyde hydrogen (Figure 5.5). One problem
encountered during the purification was that it was necessary to dissolve 63 in CH2Cl2
due to its low solubility in hexane.

O

H3CO

H

O

O
64

Figure 5.3. 1H NMR spectrum of 63 showing distinguishable proton resonances

Serving as the key step for 65, the cycloaddition of 64 with isoprene in xylene at
90 and 150 ºC, respectively, revealed only unreacted 64. To overcome this problem, we
first dissolved 64 in CH3CN due to its low solubility in xylene. Secondly, we treated 64
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with an excess of isoprene and a few crystals of hydroquinone in a sealed tube at 50 ºC
for 24 hrs. This reaction worked well and product 65 was confirmed by 1H and 13C NMR
shown in Figure 5.4. Based on 1H NMR, an unseperable mixture of cycloadduct and
starting material were observed. The presence of two peaks at 9.2 ppm was characteristic
of the aldehyde intact and the additional resonance at 6.1ppm indicated the proton of the
alkene. Analyis of 13C NMR showed a signal at 168 and 197 ppm corresponding to the
carbonyl of the aldehyde and lactone, respectively. Furthermore, the presence of two
carbon signals at 154 and 163 ppm are consistent with the presence of the alkene
segment.

O
H

H3CO

H
O

O
65

Figure 5.4. 1H and 13C NMR spectra of 65 showing distinguishable proton resonances and carbon
signals.

The use of hydroquinone crystals turned out to be quite important experimentally. First
this group allowed us to separate the mixture of starting material 64 from product 65 by
filtration, and secondly, hydroquinone crystals prevented the polymerization of
isoprene.142,143 After the synthesis of 65, we intended to elaborate these studies by
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conversion of 65 into 66 via hydrogenation. Unfortunately, hydrogenation under a
variety of conditions (Pd/C and various solvents) failed to produce characterizable
products. Instead decomposition of the initial adduct 65 was observed. This
straightforward reaction illustrates the challenges of derivatizing 65, since it is highly
sensitive to the reaction conditions, which could drive the reverse Diels-Alder reaction to
the starting matierials (Scheme 5.10).
As stated above, coumarin derivatives were of prime importance for further
biological evaluation and analogue synthesis. Treatment of 65 with NaBH4 in ethanol
resulted in fragmentation of the starting material and consistent under mild basic
conditions due to the removal of the acidic hydrogen as exemplified by Scheme 5.10.

Scheme 5.10 Fourth model coumarin derivatives
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5.3 Conclusion
To investigate for the pertinent structural elements of diterpene structure,
synthesis of analogs for structural activity relationship studies (SARs) were investigated.
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The first diterpene analogs were designed to introduce chloride atoms in the A ring
system of diterpene. The idea was that in contrast to a phenol ring, a less reactive aryl
chloride could prevent the formation of QM. As a consequence of this work, the less
reactive aryl chloride completely prevented the full cyclization of 46. The investigation
of our diterpene analogs B, were to generate a structure containing a bromine substituent
on the aromatic system. The interest in 53 was due to its unique structure and particular
functionality. Synthesis of this compound was performed by way of our previously
reported polyene cyclization. These studies showed a temperature dependent effect on
the reaction. At room temperature an intermediate side product 51 was observed, while
at elevated temperature full cyclization proceeded to generate 53.
Further studies to establish an unsaturated double bond into the C ring system of
diterpene structure via the Heck reaction were unsuccessful. The corresponding products
of this reaction were characterized and identified as a fragmented segment of the starting
material 50. The disconnected products of this reaction were attributed to the formation
of an enolated during the migration of the PdBr in the reaction pathway. Continuing our
synthesis of SARs, a Diels-Alder reaction for the generation of coumarin derivatives 65
was investigated. It was anticipated that the biological activity of structurally interesting
diterpene analogs could be enhanced by the substitution of the benzylic hydrogens. To
this end a lactone ring system was selected to replace the labile benzylic hydrogens with
that of an oxygen group. Results of these studies showed that 65 could be formed
conveniently by treatment with isoprene, xylene, and subsequent addition of
hydroquinone and heated in a closed reaction vessel.

93
These diterpene analogs should provide a good fundamental basis for testing the
chemo structural features involved in the biological properties of diterpene and cisterpenone structure.
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Chapter 6
Future studies on diterpenone as potent chemopreventive agents
6.1 Introduction
In the previous chapter 5, synthesis of diterpene analogs for structural activity
relationship was investigated. Due to the synthetic challenges presented during the
synthesis of our desired targets, this study is not fully completed. However with the
compounds successfully synthesized, we were able to achieve a diverse set of structures.
In this chapter, we have arranged diterpene analogs and related compounds into different
classes so that we could more easily correlate their activity to our original cis-terpenone
structure. The goal of these studies was to increase our understanding of the mechanistic
action of cis-terpenones.

6.2 Initial studies and future efforts
Successful chemopreventive agents against AFB1 should demonstrate better
physiochemical properties such as increased solubility and cellular absorption for
maximum protective effects in biological systems. Therefore the structures in Scheme
6.1 represent chemical modifications of our unique diterpenes and interesting synthetic
intermediates. These compounds will be screened to evaluate their chemical structural
features and to investigate their effects in human liver cells against AFB1 toxicity.
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Scheme 6.1 Comparison of chemical structure and derivatives of diterpenone
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The first group of compounds were designed to examine the effects of substitution
by a halogen group and to compare mon-versus diketone functional groups. The diketone
structures were synthesized and characterized in collaboration with Dr. Zhou. Compounds
in the second group were designed to evalutate the protective effects of compounds having
a cyclic epoxide or alkene functional groups. This group will also be used to determine
whether substitution of the uncyclized form of diterpene skeleton has potential biological
activities. Finally, the elimination of the alpha hydrogens in all four compounds of group
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three will allow us to investigate whether this position is necessary for chemoprotection.
The biological investigations of these compounds using cell viability assay experiments are
still in progress at this stage. This work provides the basis for a chemopreventive
intervention strategy based on cis-terpenone and demonstrates the potential for developing
cis-terpenones as effective chemopreventive agents.
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Experimental Section

General methods. All solvents and chemicals were purchased from Fisher
Scientific (Pittsburgh, PA) or Sigma-Aldrich (Milwaukee, WI) and used without further
purification. The flash column chromatographic separations were performed with silica
gel 60 (230-400 mesh). All 1H NMR and 13C NMR spectra were recorded on Varian 300
and 400 NMR spectrometers. All NMR chemical shifts (δ) were reported in parts per
million (ppm) and were determined relative to the standard values for deuterated solvents.
Electrospray ionization mass spectroscopy (ESI-MS) analysis was carried out using QTOF2 from Micromass (Manchester, U.K.). Some compounds were separated and
quantified analytically by a Varian reversed-phase C18 column using a Jasco HPLC
system.
Isopropyl (4E)-2-(3,4-Dimethoxyphenyl)-5,9-dimethyl-deca-4,8-dienoate (7).
To a solution of fresh distilled diisopropylamine (3.1 mL, 22 mmol) in dry THF (10 mL) at
-78 ºC under N2 was added a solution of n-butyllithium (2.5 M, 8.8 mL). After 10 min at
-78 ºC, a solution of 3,4-dimethoxyphenylacetic acid (2.0 g, 10 mmol) in dry THF (10 mL)
was slowly added. The resulting solution was stirred for 1 h at -78 ºC , and then, geranyl
chloride (2.0 mL, 11 mmol) was added. The reaction solution was stirred under N2 for 18
h and allowed to slowly warm to room temperature. The reaction solution was then
quenched with 1 N HCL (250 mL) and extracted with CH2Cl2. The organic layers were
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collected, washed with brine, dried with MgSO4, and concentrated. Flash chromatographic
separation (0.5-7% MeOH in CH2Cl2) afforded the free acid 6 as a yellow oil (3.0 g) in
89% yield. 1H NMR (CDCl3, 300MHz): δ 6.87-6.79 (m, 3H), 5.06-4.99 (m, 2H), 3.87(s,
3H), 3.85 (s, 3H), 3.49 (t, Ј= 7.5Hz, 1H), 2.79-2.69 (m, 1H), 2.50-2.40 (m, 1H), 2.00-1.93
(m, 4H), 1.64 (s, 3H), 1.56 (s, 3H), 1.56 (s, 3H).

13

C NMR (CDCl3, 75 MHz): δ 179.4,

149.1, 148.5, 138.0, 131.6, 130.9, 124.2, 120.7, 120.5, 111.2, 111.2, 56.0, 51.4, 39.9, 31.9,
26.7, 25.8, 17.8, 16.3. HRMS calcd for C20H28O4, 332.1988; found, 332.2003.
To a solution of the resulting acid 6 (3.0 g, 9.0 mmol) in CH2Cl2 (25 mL) were
added 4-(dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDCI) (1.7 g 1.1
mmol) and 2-propanol (0.76 ml, 9.9 mmol). Flash chromatographic separation (510%EtOAc in hexanes) afforded product 7 as a colorless oil (2.5 g) in 76% yield. 1H
NMR (CDCl3, 300 MHz): δ 6.87-6.77 (m, 3H), 5.06-4.96 (m, 3H), 3.87 (s, 3H), 3.85 (s,
3H), 3.43 (t, Ј= 7.9 Hz, 1H), 2.77-2.67 (m, 1H), 2.45-2.35 (m, 1H), 2.00-1.93 (m, 4H),
1.66 (s, 3H), 1.57 (s, 6H), 1.21 (d, Ј = 6.3 Hz, 3H), 1.14 (d, Ј=6.3 Hz, 3H). 13C NMR
(CDCl3, 75MHz): δ 173.7, 148.9, 148.2, 137.6, 132.0, 131.6, 124.3, 121.1, 120.0, 111.1,
111.0, 68.0, 56.0, 51.9, 39.9, 32.6, 26.8, 25.9, 22.0, 21.8, 17.8, 16.4. HRMS calcd for
C23H34O4, 374.2457; found, 374.2463.
1,2,3,4,4a,9,10,10a-Octahydro-6,7-dimethoxy-1,14a-trimethylphenanthrene-9carboxylic acid (9). To a solution of 7 (2.5 g, 6.8 mmol) in dry CH3NO2 (20 ml) at -15ºC
was added BF3NO2 (1.6 mL, 13 mmol), and the resulting reaction solution was stirred
under N2 at -15ºC for 2 h and then room temperature for 0.5 h. The reaction solution was
diluted with a solution of saturated NaHCO3 (150 mL) and extracted with CH2Cl2. The
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organic layers were collected, washed with brine, dried with MgSO4, and concentrated.
Flash chromatographic separation (10-12% EtOAc in hexanes) afforded the
diastereoisomeric mixture of isopropyl ester 8 as a colorless oil (2.1 g) in 61% yield. This
diastereoisomers were not further separated since one of the chiral centers was removed
during the decarboxylation step. 1H NMR (CDCl3, 300 MHz) for the major isomer: δ 6.76
(s, 1H), 6.63 (s, 1H), 5.12-5.00 (m, 1H), 3.84 (s, 3H), 3.80 (s, 3H), 3.80-3.79 (m, 1H),
2.26-1.99 (m, 3H), 1.77-1.41 (m, 6H), 1.29-1.16 (m, 10H), 0.97 (s, 3H).

13

C NMR

(CDCl3, 75 MHz) for the isomers: δ 175.2, 174.9, 148.0, 147.0, 142.9, 123.9, 112.1, 110.3,
107.6, 67.9, 55.8, 55.6, 48.9, 46.9, 41.5, 39.0, 37.3, 33.3, 33.1, 24.8, 23.1, 21.8, 21.7, 21.4,
19.1. HRMS calcd for C23H34O4, 374.2457; found, 374.2446.
To a solution of the resulting ester 8 (2.0 g, 5.3 mmol) in ethanol (20 mL) was
added crushed NaOH pellet (2.1 g ), and the resulting mixture was refluxed for 3 h. The
reaction solution was acidified with 2.5 N HCl (150 mL), and the aqueous solution was
then extracted with CH2Cl2. The organic layers were collected, washed with brine, dried
with MgSO4, and concentrated to afford the diastereoisomeric mixture of 9 as viscous oil
(1.7 g) in 96% yield. 1H NMR (CDCl3, 300 MHz) for the major isomer: δ 6.77 (s, 1H),
6.67 (s, 1H), 3.84 (s, 3H), 3.81 (s, 3H), 3.81 (m, 1H), 2.34-2.17 (m, 2H), 2.07-1.98 (m,
1H), 1.76-1.16 (m, 9H), 0.94 (s, 3H), 0.94 (s, 3H).

13

C NMR (CDCl3, 75 MHz) for the

major isomer: δ 182.0, 148.3, 147.1, 143.3, 122.9, 111.0, 107.8, 56.1, 56.0, 49.2, 46.5,
41.7, 39.2, 37.5, 33.6, 33.3, 24.9, 23.6, 21.6, 19.5. HRMS cacld for C20H28O4, 332.1988;
found, 332.1985.
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1,2,3,4,4a,10a-Hexahydro-6,7-dimethoxy-1,1,4a-trimethylphenanthrene (10).
To a mixture of 9 (1.6 g, 4.8 mmol), lead (IV) acetate (4.8 g, 11 mmol), and copper (II)
acetate (0.98 g, 5.4 mmol) was added quinoline (30 mL). The resulting dark solution was
degassed under vacuum and then heated under N2 at 130 ºC for 3 h. After it was cooled to
room temperature, the reaction solution was diluted with 1 N HCL and extracted with
CH2Cl2. The organic layers were collected, washed with brine, dried with MgSO4, and
concentrated. Quinoline from the resulting residue was removed by vacuum distillation.
Flash chromatographic separation (5-10% EtOAc in hexanes) afforded product 10 as a
colorless oil (720 mg) in 51% yield. 1H NMR (CDCl3, 400 MHZ): δ 6.72 (s, 1H), 6.60 (s,
1H), 6.45 (d, Ј= 2.8 Hz, 1H), 5.91 (d, Ј=2.8Hz, 1H), 3.87 (s, 3H), 3.84 (s, 3H), 2.14-2.08
(m, 2H), 1.77-1.49 (m, 4H), 1.26-1.19 (m, 1H), 1.03 (s, 3H), 1.00 (s, 3H), 0.96 (s, 3H).
13CNMR (CDCl3, 75 MHz): δ148.3, 146.8, 141.4, 128.7, 127.1, 126.1, 110.1, 106.3,
56.2, 56.1, 51.5, 41.2, 37.9, 36.4, 33.0, 32.8, 22.7, 20.2, 19.2. HRMS calcd for
C19H26O2, 286.1933; found, 286.1944.
4b, 5, 6, 7, 8, 8a-Hexahydro-2-3-dimethoxy-4b,8,8-trimethylphenanthren9(10H)-one (11). To a solution of 10 (184 mg, 0.64 mmol) in CH2Cl2 (10 mL) at 0 ºC
was added m-chloroperoxybenzoic acid (70-75%, 220 mg). The resulting reaction solution
was stirred at 0 ºC under N2 for 3 h. The reaction solution was quenched with a solution
of 5% Na2S2O3 and extracted with CH2Cl2. The organics were collected, washed with
brine, dried with MgSO4, and concentrated. The residue was dissolved with in CHCl3 (10
mL), and trifluoroacetic acid (1 mL) was added. The resulting solution was stirred under
N2 for 18 h and then diluted in CH2Cl2 (100 mL). The organic solution was washed with
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solutions of saturated NaHCO3 and brine, dried with MgSO4, and concentrated. Flash
chromatography separation (10-15% EtOAc in hexanes) afforded product 11 as a colorless
oil (88 mg) in 45% yield. 1H NMR (CDCl3, 400 MHz): δ 6.83 (s, 1H), 6.53 (s, 1H), 3.88
(s, 3H), 3.85 (s, 3H), 3.55 (s, 2H), 2.41 (s, 1H), 2.31-2.27 (m, 1H), 1.79-1.68 (m, 3H),
1.45-1.39 (m, 1H), 1.31 (s, 3H), 1.31-1.16 (m, 1H), 1.14 (s, 3H), 1.08 (s, 3H).

13

C NMR

(CDCl3, 75MHz): δ 209.8, 147.9, 147.7, 124.4, 111.0, 107.4, 63.0, 56.3, 56.1, 44.9, 42.9,
40.6, 39.0, 33.1, 32.7, 24.9, 21.7, 18.9. HRMS calcd for C19H26O3, 302.1882; found,
302.1898.
4b, 5, 6, 7, 8, 8a-Hexahydro-2-3-dimethoxy-4b,8,8-trimethylphenanthren9(10H)-one (1). To a mixture of 11 (50 mg, 0.17 mmol) in CH2Cl2 (3.0 mL) under N2 was
added BBr3 (1.0 M in heptane, 0.5 mL, 0.5 mmol). The resulting dark solution was stirred
at room temperature for 2 h. The reaction solution was quenched with a solution of brine
and extracted with degassed EtOAc. The organic layers were collected, dried with MgSO4,
and concentrated. Flash chromatographic separation (25-35% EtOAc in hexanes) under N2
afforded product 1 as a brown oil (38 mg) in 82% yield. 1H NMR (CD3CN, 400 MHz): δ
6.80 (s, 1H), 6.58 (br s, 1H), 6.51 (s, 2H), 3.52 (d, Ј = 21Hz, 1H), 3.38 (d, Ј= 21 Hz, 1H),
2.41 (s, 1H), 2.26-2.23 (m, 2H), 1.76-1.69 (m, 1H), 1.63-1.60 (m, 2H), 1.40-1.36 (m, 1H),
1.27 (s, 3H), 1.21-1.16 (m, 1H), 1.08 (s, 3H), 1.04 (s, 3H).

13

C NMR (CD3CN, 75 MHz): δ

209.9, 143.3, 142.9, 141.3, 124.3, 114.7, 110.9, 62.4, 44.3, 42.5, 40.1, 38.7, 32.4, 32.3,
24.3, 21.2, 18.7. ESI-MS calcd for C34H44O6-H+ (dimer), 547, and for C17H22O3-H+, 273;
found, 547 and 273.
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Formation of Diterpene QM under Organic Conditions. The oxidation of
catechols was achieved using Ag2O as an oxidant. After vigorous stirring at ambient
temperature for 20 min, the solids were removed by filtration with a 0.2µm filter
(Acrodisc, 13 CR, PTFE).
Diterpene QM 3 (5 mg in 0.8 mL CDCl3). 1H NMR (CD3CN, 400 MHz): δ 7.43
(br, 1H), 6.51 (s, 1H), 6.40 (s, 1H), 6.30 (s, 1H), 2.60 (s, 1H), 1.80-1.60 (m, 4H), 1.40-1.20
(m, 2H), 1.24 (s, 6H), 1.15 (s, 3H). Because of high reactivity 13C NMR was unsuccessful.
1-(Chloromethyl)-3,4-dimethoxy-2-methylbenzene (15). To a solution of chloro
methyl ethyl ether (6.05 g, 64.0 mmo) in acetic acid (5.5 mL) was added 2,3dimethoxytoluene 14 (5.20 mL, 34.7 mmol), and the reaction was initiated by slightly
heating. The reaction solution was stirred under N2 at room temperature for 16 h and then
cooled in ice to precipitate the product. The solid was collected by filtration and washed
with water. Flash chromatographic separation (5-10% EtOAc in hexanes) afforded
compound 15 as a white solid (3.21 g) in 47% yield. 1H NMR (CDCl3, 300 MHz): δ 7.04
(d, Ј = 8.3 Hz, 1H), 6.73 (d, Ј = 8.3 Hz, 1H), 4.58 (s, 2H), 3.85 (s, 3H), 3.79 (s, 3H), 2.35
(s, 3H).

13

C NMR (CDCl3, 75 MHz): δ 153.4, 147.7, 131.9, 129.0, 125.9, 109.5, 60.5,

55.8, 45.6, 11.6. ESI-MS calcd for C10H13ClO2 (M-Cl), 165.09; found, 165.05
3,4-Dimethoxy-2-methylphenylacetic acid (17). To a solution of 15 (3.21 g, 16.0
mmol) in dry DMF (35 mL) was added KCN (1.03 g, 1.05 equiv) and 18-crown-6 (5.04 g,
1.2 equiv). The reaction was stirred under N2 for 16 h. The reaction solution was then
extracted with ether (250 mL x 2). The organic layers were collected, dried with MgSO4,
and concentrated. Flash chromatographic separation (5-10% EtOAc in hexanes) afforded
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the cyanide product 16 as an oil (2.81 g) in 92% yield. 1H NMR (CDCl3, 300MHz): δ
7.02 (d, Ј = 8.4 Hz, 1H), 6.74 (d, Ј = 8.4 Hz, 1H), 3.83 (s, 3H), 3.76 (s, 3H), 3.58 (s, 2H),
2.23 (s, 3H), 13C NMR (CDCl3, 75 MHz): δ 152.8, 147.8, 130.6, 124.3, 121.6, 118.1,
109.9, 60.6, 55.9, 21.8, 12.1. ESI-MS calcd for C11H15NO2 (M + H+), 192.10; found,
192.07. The cyanide adduct (2.81 g, 14.7 mmol) was refluxed in a solution of NaOH (8.5
g) in ethanol (30 mL) for 18h. The reaction solution was then acidified with HCl to pH 2
and extracted with CH2Cl2. The organic layers were collected, dried with MgSO4, and
concentrated. Flash chromatography separation (2-7% MeOH in CH2Cl2) afforded
compound 17 as white solid (1.95 g) in 63% yield. 1H NMR (CDCl3, 300MHz): δ6.91 (d,
Ј = 8.3 Hz, 1H), 6.72 (d, Ј = 8.3 Hz, 1H), 3.83 (s, 3H), 3.77 (s, 3H), 3.60 (s, 2H), 2.21 (s,
3H).

13

C NMR (CDCl3, 75 MHz): δ 178.4, 152.3, 147.5, 131.6, 126.0, 125.5, 109.7, 60.4,

55.8, 38.9, 12.4. ESI-MS calcd for C11H15O4 (M + H+), 211.10; found 211.10.
Methyl (4E)-2-(3,4-Dimethoxy-2-methylphenyl)-5,9-dimethyldeca-4,8-dienoate
(18). To a solution of freshly distilled diisopropylamine (2.20 mL, 15.7 mmol) in dry THF
(20 mL) at -78C under N2 was added a solution of n-butyllithium (2.5 M, 6.28 mL). After
10 min at -78 ºC, a solution of 3,4-Dimethoxyphenylacetic acid (1.40 g, 7.13 mmol) in
THF (10 mL) was slowly added. The resulting solution was stirred for 1 h at

-78 ºC,

and then geranyl chloride (1.45 mL, 7.85 mmol) was added. The reaction solution was
stirred under N2 for 18 h and then allowed to slowly warm to room temperature. The
reaction solution was then quenched with 1 N HCl (250 mL) and extracted with CH2Cl2.
The organic layers were collected, washed with brine, dried with MgSO4 and concentrated.
Flash chromatographic separation (0.5-7% MeOH in CH2Cl2) afforded the free acid (not
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numbered) as a yellow oil (1.65 g) in 70% yield. 1H NMR (CDCl3, 300 MHz): δ7.06 (d, Ј
= 8.6 Hz, 1H), 6.75 (d, Ј = 8.6 Hz, 1H), 5.04 (m, 2H), 3.83 (s, 3H), 3.76 (s, 3H), 3.76 (m,
1H), 2.77-2.70 (m, 1H), 2.41-2.34 (m, 1H), 2.29 (s, 3H), 2.00-1.94 (m, 4H), 1.65 (s, 3H)
1.57 (s, 6H).

13

C NMR (CDCl3, 75 MHz): δ 180.5, 151.9, 147.2, 137.8, 131.6, 131.2,

130.3, 124.3, 122.8, 120.9, 109.8, 60.5, 55.8, 47.0, 39.9, 31.6, 26.7, 25.8, 17.8, 16.3, 12.1.
ESI-MS calcd for C21H31O4 (M + H+), 347.22; found 347.22.
To a solution of the resulting free acid (1.57 g, 4.72 mmol) in CH2Cl2 (35 mL) were
added 4-(dimethyamino)pyridine (6.81 mg, 1.2 eq), DCC (1.16 g, 1.2 eq) and methanol
(210 µL, 1.1 eq). The resulting reaction mixture was stirred under N2 for 18 h at room
temperature. The reaction solution was then quenched with 1 N HCl (250 mL) and
extracted with CH2Cl2. The organic layers were collected, washed with brine, dried with
MgSO4 and concentrated. Flash chromatographic separation (5-20%EtOAc in hexanes)
afforded diastereoisomeric pure trans compound 18 as a yellow oil (1.03 g) in 60% yield.
1

H NMR (CDCl3, 300MHz): δ 7.04 (d, Ј = 8.5 Hz, 1H), 6.74 (d, Ј = 8.5 Hz, 1H), 5.05-

5.00 (m, 2H), 3.83 (s, 3H), 3.77 (s, 3H), 3.76 (m, 1H), 3.64 (s, 3H), 2.76-2.71 (m, 1H),
2.38-2.34 (m, 1H), 2.27 (s, 3H), 2.00-1.93 (m, 4H) 1.66 (s, 3H) 1.57 (s, 6H).

13

C NMR

(CDCl3, 75 MHz): δ 174.9, 151.7, 147.2, 137.6, 131.6, 130.9, 130.8, 124.3, 122.6, 121.2,
109.7, 60.4, 55.8, 52.0, 47.1, 39.9, 32.1, 26.8, 25.9, 17.8, 16.3, 12.0. ESI-MS calcd for
C22H33O4 (M + H+), 361.24; found 361.24.
4b, 5, 6, 7, 8, 8a-trans-Hexahydro-2,3-dimethoxy-1,4b,8,8tetramethylphenanthrenene (21) To a solution of 18 (992 mg, 2.73 mmol) in dry
CH3NO2 (20 mL) at -15 ºC was added BF3OEt2 (2.40 mL, 7eq), and the resulting solution
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was stirred under N2 at -15 ºC for 4 h. The reaction solution was diluted with saturated
NaHCO3 (150 mL) and extracted with CH2Cl2 (150 mL x3). The organic layers were
collected, washed with brine, dried with MgSO4 and concentrated. Flash chromatographic
separation (5-10% EtOAc in hexanes) afforded the diastereoisomeric mixture of isopropyl
ester 19 as colorless oil (619 mg) in 71% yield. These diastereoisomers were not further
separated since one of the chiral centers was removed during the decarboxylation step. 1H
NMR (CDCl3, 300MHz): δ 6.73 (s, 1H), 3.83 (s, 3H), 3.73 (s, 3H), 3.69 (s, 3H), 3.66 (m,
1H), 2.33-2.23 (m, 1H), 2.02 (s, 3H), 1.79-1.17 (m, 11H), 0.94-0.88 (m, 6H)

13

C NMR

(CDCl3, 75 MHz): δ 177.1, 151.3, 147.1, 145.3, 131.03, 123.9, 106.6, 105.9, 60.4, 55.7,
52.3, 48.6, 46.6, 45.2, 44.2, 41.7, 41.3, 39.7, 39.0, 38.0, 33.6, 33.2, 33.0, 25.2, 25.1, 24.7,
24.0, 21.7, 19.5, 19.4, 12.3, 12.1. ESI-MS calcd for C22H33O4 (M + H+), 361.24; found
361.24.
To a solution of the resulting ester (617 mg, 1.70 mmol) in ethanol (20 mL) was
added 3 g crushed NaOH pellets, and the resulting mixture was refluxed for 3 h. The
reaction solution was acidified with 2.5 N HCl and extracted with CH2Cl2. The organic
layers were collected, washed with brine, dried with MgSO4, and concentrated to afford a
diastereoisomeric mixture of 20 as a viscous oil (432 mg) in 73% yield. 1H NMR (CDCl3,
300MHz): δ 6.75 (s, 1H), 3.84 (s, 3H), 3.84 (m, 1H), 3.75 (s, 3H), 2.45-2.17 (m, 2H), 2.11
(s, 3H), 1.89-1.18 (m, 10H), 0.96-0.94 (m, 6H).

13

C NMR (CDCl3, 75 MHz): δ 182.9,

181.9, 152.1, 151.5, 147.3, 146.9, 145.3, 140.3, 131.1, 125.2, 123.3, 107.2, 106.5, 106.0,
60.5, 60.4, 55.8, 50.3, 48.6, 46.6, 44.8, 44.0, 42.1, 41.8, 41.3, 39.7, 39.0, 38.9, 38.7, 37.9,
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37.7, 34.9, 34.4, 33.7, 33.2, 33.0, 32.7, 25.2, 24.6, 24.0, 21.7, 21.7, 19.5, 12.4, 12.0. ESIMS calcd for C21H31O4 (M + H+), 347.22; found, 347.22.
To the resulting mixture (398 mg, 1.25 mmol), lead (IV) acetate (1.20 g. 2.2 equiv)
and copper (II) acetate (248 mg, 1.1 equiv), was added quinoline (15 mL). The resulting
dark solution was degassed under vacuum and then heated under N2 at 140 ºC for 3 h.
After cooling to room temperature, quinoline from the resulting was removed by vacuum
distillation. The reaction solution was diluted with 1 N HCl (200 mL) and extracted with
CH2Cl2 (150 mL x 3). The organic layers were collected, washed with brine, dried with
MgSO4, and concentrated. Flash chromatographic separation (5-20% EtOAc in hexanes)
afforded product 21 as a colorless (200 mg) in 53% yield. 1H NMR (CDCl3, 300MHz): δ
6.68 (d, Ј=2.8Hz, 1H), 6.64 (s, 1H), 5.95 (d, Ј=2.8Hz, 1H), 3.86 (s, 3H), 3.75 (s, 3H), 2.26
(s, 3H), 2.19-2.07 (m, 2H), 1.75-1.50 (m, 4H), 1.24-1.20 (m, 1H), 1.05 (s, 3H), 1.02 (s,3H),
0.97 (s,3H).

13

C NMR (CDCl3, 75 MHz): δ 151.9, 145.2, 145.0, 128.4, 127.9, 125.2,

124.2, 104.4, 60.5, 55.9, 50.7, 41.2, 38.5, 36.6, 33.0, 32.7, 22.7, 20.1, 19.3, 11.8. ESI-MS
calcd for C20H29O2 (M + H+), 300.21; found 300.09.
4b, 5, 6, 7, 8, 8a-trans-Hexahydro-2,3-dimethoxy-1,4b,8,8tetramethylphenanthrenene-9(10H)-one (22F). To a solution of 21 (270 mg, 0.899
mmol) in CH2Cl2 (10 mL) at 0 ºC was added m-chloroperoxbenzoic acid (70-75%, 443
mg, 1.5 equiv). The resulting reaction was stirred at 0 ºC under N2 for 3h. The reaction
was quenched with a solution of 5% NaHCO3 (150 mL) and extracted with CH2Cl2 (150
mL x 3). The organic layers were collected, washed with brine, dried with MgSO4 and
concentrated. Flash chromatographic separation (5-10% EtOAc in hexanes) afforded
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product 22F as a colorless oil (119 mg) in 41% yield. 1H NMR (CDCl3, 300 MHz): δ 6.76
(s, 1H), 3.85 (s, 3H), 3.76 (s, 3H), 3.46 (d, J= 21.4Hz, 1H), 3.37 (d, J= 21.4Hz, 1H), 2.44
(s, 1H), 2.30-2.28 (m, 1H), 2.10 (s, 3H), 1.72-1.64 (m, 4H), 1.43-1.38 (m, 1H), 1.32 (s,
3H), 1.18 (s, 3H), 1.06 (s, 3H). 13C NMR (CDCl3, 75MHz): δ 209.7, 151.4, 145.8, 144.7,
129.7, 124.0, 105.8, 62.4, 60.5, 56.0, 43.5, 42.8, 41.1, 39.1, 33.0, 32.7, 25.1, 21.8, 19.0,
12.1. ESI-MS calcd for C20H29O3 (M + H+), 317.21; found, 317.20.
4b, 5, 6, 7, 8, 8a-trans-Hexahydro-2,3-dihydroxy-1,4b,8,8tetramethylphenanthrenene-9(10H)-one (23). To a mixture of 22F (11 mg, 0.35
mmol) in CH2Cl2 (3.0 mL) under N2 was added BBr3 (1.0 M in heptane, 0.5 mL, 0.5
mmol). The resulting dark solution was stirred at room temperature for 2h. The reaction
solution was quenched with a solution of brine and extracted with degassed EtOAc. The
organic layers were collected, dried with MgSO4, and concentrated. Flash
chromatographic separation (25-35% EtOAc in hexanes) under N2 afforded product 23 as a
brown oil (5.4 mg) in 54% yield. 1H NMR (CDCl3/CD3OD, 300 MHz): δ 6.64 (s, 1H),
3.53 (s, 2H), 3.43-3.18 (q, J= 21.4Hz, 2H), 2.39 (s, 1H) 2.17-2.14 (m, 1H), 2.01 (s, 3H),
1.63-1.53 (m, 4H), 1.35-1.30 (m, 1H), 1.24 (s, 3H), 1.02 (s, 3H), 0.97 (s, 3H). 13C NMR
(CDCl3/CD3OD, 75MHz): δ 207.5, 138.9, 137.2, 136.8, 118.8, 118.2, 104.0, 58.7, 39.6,
38.8, 36.7, 35.1, 28.9, 28.6, 21.2, 17.7, 15.0, 7.6. ESI-MS calcd for C18H25O3 (M+),
288.17; found, 288.09
4b, 5, 6, 7, 8, 8a-trans-Hexahydro-4b,8,8-trimethylphenanthrene-2,3-diol (25).
To a solution of 10 (100 mg, 0.35 mmol) in CH2Cl2 (3.0 mL) under N2 was added BBr3
(1.0 M in heptane, 0.5 mL, 0.5 mmol). The resulting dark solution was stirred at room
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temperature for 2h. The reaction solution was quenched with a solution of brine and
extracted with degassed EtOAc. The organic layers were collected, dried with MgSO4, and
concentrated. Flash chromatographic separation (25-35% EtOAc in hexanes) under N2
afforded product 25 as a brown oil (5.4 mg) in 80% yield. 1H NMR (CDCl3, 300MHz): δ
6.71 (s, 1H), 6.58 (s, 1H), 6.39 (d, J= 8.7 Hz, 1H), 5.90 (d, J= 8.7 Hz, 1H), 5.14 (br s, 1H)
4.94 (br s, 1H), 2.06 (br m, 2H), 1.72-1.49 (m, 3H), 1.27-1.21 (m, 2H), 1.02 (m, 3H), 0.99
(s, 3H), 0.96 (s, 3H).

13

C NMR (CDCl3, 75 MHz): δ 142.9, 142.6, 140.9, 128.8, 126.9,

126.7, 113.8, 110.1, 51.3, 41.2, 37.9, 36.3, 33.0, 32.8, 22.7, 20.5, 19.2. ESI-MS calcd for
C17H23O2 (M+), 258.16; found, 258.08.
4b, 5, 6, 7, 8, 8a-trans-Hexahydro-4b,8,8-trimethylphenanthrene-2,3-diol (26).
To a solution of 21 (32 mg, 0.11 mmol) in CH2Cl2 (2.0 mL) under N2 was added BBr3 (1.0
M in heptane, 1 mL). The resulting dark solution was stirred at room temperature for 2h.
The reaction solution was quenched with a solution of brine and extracted with degassed
EtOAc (100 mL x 2). The organic layers were collected, dried with MgSO4, and
concentrated. Flash chromatographic separation (25-35% EtOAc in hexanes) under N2
afforded product 26 as a brown oil (20 mg) in 68% yield. 1H NMR (CDCl3/CD3OD, 300
MHz): δ 6.61 (d, J= 3.0 Hz, 1H), 6.53 (s, 1H), 5.86 (d, J= 2.8 Hz, 1H), 3.51 (s, 2H), 2.18
(s, 3H) 2.00-1.97 (m, 2H), 1.67-1.42 (m, 4H), 1.21-1.15 (m, 2H), 0.98 (s, 3H), 0.93 (s,
3H), 0.90 (s, 3H). 13C NMR (CDCl3/CD3OD, 75 MHz): δ 143.2, 141.6, 140.3, 127.9,
124.5, 124.2, 120.9, 106.9, 50.9, 41.2, 38.0, 36.5, 32.9, 32.7, 22.5, 20.2, 19.2, 11.3. ESIMS calcd for C18H25O2 (M+), 272.17; found, 272.09.
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General Synthetic Procedures to cis-analogues 22 and 24. To a solution of
geranyl aldehyde 27 (1 g, 6.5 mmol) in THF (25 mL) was added 1,3 propane dithiol (0.9
mL, 1.1 equiv) at -50 oC was added BF3Et2O (2.1 mL, 3 equiv) and the resulting reaction
solution was stirred under N2 for 3 h. The reaction was quenched with a solution of 5%
Na2S2O3 and extracted with CH2CL2 (100 mL x 2). The organic layers were collected,
washed with brine, dried with MgSO4, and concentrated. Flash chromatographic
separation (10-15% EtOAc in hexanes) afforded product 28 in 71% yield as a colorless oil
(1:1 cis/trans mixture). To a solution of thiol-protected citral 28 (1:1 cis/trans mixture) in
dry THF (20 mL) at -40 ºC (acetonitrile/dry ice bath) was slowly added a solution of 1.05
equiv n-BuLi (1.6 M in hexanes) under N2. The resulting reaction solution was stirred at 40 ºC for 1 h, and then a solution of (0.95 equiv) 15a or 15b in dry THF (10 mL) was
added. After 4h, the reaction flask was transferred into a dessicator and kept in a freezer (25 ºC) for 48 hours. The reaction solution was quenched with brine (100 mL) and
extracted with ether (100 mL x 2 ). The organic layers were collected, dried with MgSO4,
and concentrated. The desired products 29a,b were purified as cis/trans diastereiomeric
mixture by a flash column separation. Further separation of the isomers was not carried
out because the subsequent cyclization step afforded diastereoismerically pure ciscompounds.
To a solution of 29a,b in MeOH/H2O (9:1, 25 mL) was added 1.1 equiv HgO and
HgCl2. Prior to this study, we investigated the effect of CaCO3 in the reaction mixture, to
neutralize the HCL formed in the reaction, but we found that the reaction worked better
with the combination of HgO and HgCl2 in a 1/1 ratio. Therefore, after addition of HgO
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and HgCl2, the resulting reaction solution was stirred at room temperature for 12 h. The
reaction solution was diluted with CH2Cl2, and the precipitation was filtered through
Celite. The solution was washed with brine, collected, dried with MgSO4, and
concentrated. The desired products 30a,b were purified as a cis/trans diastereomeric
mixture by a flash column separation using (10-15% EtOAc in hexanes).
To a solution of 30a,b in dry CH3NO2 (10 mL) at room temperature was added 10
equiv BF3OEt2, and the resulting reaction solution was stirred under N2 for 2 h. The
reaction solution was diluted with saturated NaHCO3 (150 mL) and extracted with CH2Cl2
(150 mL x 3). The organic layers were collected, dried with MgSO4, and concentrated.
The desired compounds 31a,b were purified as a diastereoisomeric pure product by a flash
column separation (10-25% EtOAc in hexanes). To a solution of 31a,b in CH2Cl2 (2.0
mL) under N2 was added a solution of BBr3 (1.0 M in hepatane, 1.0 mL). The resulting
solution was stirred at room temperature for 2h. The reaction solution was quenched with
brine (100 mL) and extracted with EtOAc (100 mL x 2). The organic layers were
collected, dried with MgSO4, and concentrated. The desired products 22 and 24 were
purified by a flash column separation (1-5% MeOH in dichloromethane).
2-(3,4-Dimethoxybenzyl)-2-(2,6-dimethylhepta-1,5-dienyl)-1,3-dithiane (29a).
A colorless oil: 1.29 g in 63% yield (10-25% EtOAc in hexanes). 1H NMR
(CDCl3, 300 MHz) for the cis/trans diastereomeric mixture: δ 6.80-6.77 (m, 3H), 5.40 (s,
1H), 5.15-5.07 (2 sets of triplet, J= 6.7 Hz, 1H), 3.83 (s, 6H), 3.27-3.21 (2 sets of singlet,
2H), 2.92-2.78 (m, 4H), 2.49-2.44 (m, 1H), 2.10-2.05 (m, 5H), 1.80 (2 sets of singlet, 3H),
1.66 (s, 3H), 1.59 (2 sets of singlet, 3H).

13

C NMR (CDCl3, 75 MHz) observed: δ 148.2,
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142.8, 142.2, 132.0, 131.9, 128.6, 128.4, 128.2, 127.2, 124.4, 124.2, 123.3, 114.4, 110.5,
55.9, 54.8, 54.0, 46.8, 46.5, 41.8, 32.6, 28.1, 27.9, 26.8, 26.3, 25.9, 25.7, 25.6, 24.7, 17.9,
17.2. ESI-MS calcd for C22H33O2S2 (M+H+), 393.19; found 393.19.
2-(3,4-Dimethoxy-2methylbenzyl)-2-(2,6-dimethylhepta-1,5-dienyl)-1,3dithiane (29b). A colorless oil: 1.18 g in 54% yield (5-25% EtOAc in hexanes). 1H
NMR (CDCl3, 300 MHz) for the cis/trans diastereomeric mixture: δ 7.05 (d, J=8.5 Hz,
1H), 6.67 (d, J= 8.5 Hz, 1H), 5.42 (s, 1H), 5.42 (s, 1H), 5.05 (t, J =5.4 Hz, 1H), 3.80 (s,
3H), 3.72 (s, 3H), 3.27-3.21 (2 sets of singlet, 2H), 2.97-2.87 (m, 2H), 2.74-2.66 (m, 2H),
2.25 (s, 3H), 2.10-1.96 (m, 6H), 1.66 (s, 3H), 1.62 (s, 3H), 1.58 (s, 3H).

13

C NMR (CDCl3,

75 MHz) observed: δ 151.7, 147.2, 142.6, 141.9, 132.4, 131.8, 131.5, 128.5, 127.9, 127.7,
127.6, 127.5, 124.6, 124.4, 108.7, 60.2, 56.0, 55.7, 55.2, 43.7, 43.4, 42.1, 32.0, 28.2, 27.9,
26.6, 26.2, 26.0, 25.9, 25.8, 25.6, 24.9, 17.9, 16.5, 13.4. ESI-MS calcd for C22H33O2S2
(M+H+), 407.21; found 407.21.
1-(3,4-Dimethoxyphenyl)-4,8-dimethylnona-3,7-dienyl-2-one (30a).
A colorless oil: 125 mg in 62% yield (5-20% EtOAc in hexanes). 1H NMR (CDCl3, 300
MHz) for the cis/trans diastereomeric mixture: δ 6.80-6.71 (m, 3H), 6.07 (s, 1H), 5.10-5.00
(2 sets of multiplet, 1H), 3.84 (s, 6H), 3.62-3.60 (2 sets of multiplet, 2H), 2.57 (t, J=7.8 Hz,
1H), 2.12-2.09 (5H), 1.83 (s, 1H), 1.64 (s, 3H), 1.56 (s, 3H).

13

C NMR (CDCl3, 75MHz):

δ 198.6, 197.9, 160.8, 160.2, 149.1, 148.1, 132.7, 132.3, 127.7, 123.9, 123.1, 122.5, 121.8,
112.7, 111.5, 56.0, 51.3, 41.5, 34.2, 31.8, 26.9, 26.2, 26.0, 25.9, 22.8, 19.7, 17.9, 14.3 ESIMS calcd for C19H27O3 (M+H+), 303.20; found, 303.08.
1-(3,4-Dimethoxy-2-methylphenyl)-4,8-dimethylnona-3,7-dienyl-2-one (30b).
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A colorless oil: 156 mg in 50% yield (25-35% EtOAc in hexanes). 1H NMR (CDCl3, 300
MHz) for the cis/trans diastereomeric mixture: δ 6.84 (d, J=8.3 Hz, 1H), 6.72 (d, J= 8.3
Hz, 1H), 6.80-6.71 (m, 3H), 6.07 (s, 1H), 5.10-5.00 (2 sets of multiplet, 1H), 3.82 (s, 3H),
3.76 (s, 3H), 3.64 (s, 2H), 2.60 (t, J= 7.4 Hz, 1H), 2.14-2.11 (m, 8H), 1.84 (s, 1H), 1.66 (s,
3H), 1.57 (s, 3H).

13

C NMR (CDCl3, 75 MHz) observed; δ 198.6, 197.8, 160.4, 159.7,

151.8, 147.6,132.6, 132.2, 131.4, 127.4, 126.0, 123.9, 123.1, 123.0, 122.5, 109.6, 60.4,
55.8, 49.3, 41.4, 34.1, 26.9, 26.2, 26.0, 25.9, 25.8, 19.7, 17.9, 17.8, 12.5 ESI-MS calcd for
C20H29O3 (M+H+), 317.21; found, 317.21.
4b,5,6,7,8,8a-cis-Hexahydro-2,3-dimethoxy-4b,8,8-trimethylphenanthren9(10H)-one (31a). A colorless oil: 120 mg in 44% yield (25-35% EtOAc in hexanes). 1H
NMR (CDCl3, 300 MHz): δ 6.84 (s, 1H), 6.58 (s, 1H), 3.90 (s, 3H), 3.86 (s, 3H), 3.64 (d,
J= 23.0 Hz, 1H), 3.54 (d, J= 23.0 Hz, 1H), 2.47-2.42 (m, 1H), 2.09 (s, 1H), 1.58-1.53 (m,
2H), 1.34-1.31 (m, 3H), 1.05 (s, 3H), 0.94 (s, 3H), 0.36 (s, 3H). 13C NMR (CDCl3, 75
MHz): δ 212.7, 148.1, 147.7, 133.7, 126.3, 111.6, 107.8, 66.7, 56.4, 56.1, 43.9, 42.3, 38.6,
36.6, 34.4, 33.6, 32.3, 22.6, 19.1. ESI-MS calcd for C19H27O3 (M+H+), 303.20; found,
303.21.
4b,5,6,7,8,8a-cis-Hexahydro-2,3-dimethoxy-1,4b,8,8-tetramethylphenanthren9(10H)-one (31b). A colorless oil: 131mg in 62% yield (5-10% EtOAc in hexanes). 1H
NMR (CDCl3, 300 MHz): δ 6.76 (s, 1H), 3.87 (s, 3H), 3.77 (s, 3H), 3.38 (s, 2H), 2.47-2.43
(1H), 2.10 (s, 3H), 2.08 (s, 1H), 1.58-1.52 (m, 2H), 1.34-1.28 (m, 3H), 1.03 (s, 3H), 0.93
(s, 3H), 0.36 (s, 3H). 13C NMR (CDCl3, 75 MHz): δ 212.6, 151.5, 145.8, 137.1, 130.0,
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125.5, 106.0, 66.8, 60.7, 56.1, 42.2, 42.0, 39.1, 36.7, 34.2, 33.9, 32.2, 22.6, 19.1, 12.2.
ESI-MS calcd for C20H29O3 (M+H+), 317.21; found, 317.21.
4b,5,6,7,8,8a-cis-Hexahydro-2,3-dihydroxy-4b,8,8-trimethylphenanthren9(10H)-one (22). A colorless oil: 16 mg in 72% yield (5-20% EtOAc in hexanes). 1H
NMR (CDCl3 and CD3OD, 300 MHz): 1H NMR (CDCl3, 300 MHz): δ 6.86 (s, 1H), 6.58
(s, 1H), 5.35 (br, s), 5.33 (br, s), 3.59 (d, J= 23.0 Hz, 1H), 3.39 (d, J= 23.0 Hz, 1H), 2.392.35 (d, J= 13.9 Hz, 1H), 2.06 (s, 1H), 1.63-1.48 (m, 2H), 1.33-1.22 (m, 3H), 1.02 (s, 3H),
0.92 (s, 3H), 0.36 (s, 3H).

13

C NMR (CDCl3/CD3OD, 75 MHz): δ 214.1, 143.3, 142.4,

133.8, 125.7, 115.2, 111.3, 66.7, 43.6, 42.3, 38.4, 36.5, 34.4, 33.6, 32.3, 22.6, 18.9. ESIMS calcd for C17H23O3 (M+H+), 275.16; found, 275.07.
4b,5,6,7,8,8a-cis-Hexahydro-2,3-dihydroxy-1,4b,8,8-tetramethylphenanthren9(10H)-one (24). A colorless oil: 18 mg in 82% yield (25-35% EtOAc in hexanes). 1H
NMR (CDCl3, 300 MHz): δ 6.74 (s, 1H), 5.28 (s, 1H), 5.19 (s, 1H), 3.38 (s, 2H), 2.38-2.34
(d, J= 15.0Hz, 1H), 2.09 (s, 3H), 2.08 (s, 1H), 1.60-1.48 (m, 2H), 1.33-1.22 (m, 3H), 0.99
(s, 3H), 0.92 (s, 3H), 0.37 (s, 3H). 13C NMR (CDCl3, 75 MHz): δ 213.1, 142.1, 140.5,
133.7, 125.4, 122.7, 108.6, 66.7, 42.2, 42.0, 38.6, 36.6, 34.1, 32.2, 22.6, 22.5, 19.0, 11.8.
ESI-MS calcd for C18H25O3 (M+H+), 289.18; found, 289.09.
Formation of Diterpene QM under Organic Conditions. The oxidation of catechols
was achieved using Ag2O as an oxidant. After vigorous stirring at ambient temperature for
20 min, the solids were removed by filtration with a 0.2µm filter (Acrodisc, 13 CR, PTFE).
The resulting yellow solution was confirmed as analytically pure QM or quinonone by 1H
and 13 C NMR analysis.
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Diterpenone QM 32 (5 mg in 0.8 mL CDCl3). 1H NMR (CDCl3, 300 MHz): δ 6.90
(s, 1H), 6.52 (s, 1H), 6.50 (s, 1H) 6.31 (s, 1H), 2.27 (s, 1H), 1.61-1.44 (m, 2H), 1.35-1.23
(m, 4H), 1.18 (s, 3H), 0.95 (s, 3H), 0.61 (m, 3H). 13C NMR (CDCl3, 75 MHz): δ 201.8,
182.1, 155.6, 149.9, 143.2, 132.3, 122.1, 111.0, 66.9, 41.9, 41.5, 36.3, 35.8, 35.5, 31.0,
24.7, 18.5.
Diterpenone quinone 33 (5 mg in 0.8 mL CDCl3). 1H NMR (CDCl3, 300 MHz): δ
6.54 (d, J= 2.0Hz, 1H), 6.52 (d, J= 2.2Hz, 1H), 6.20 (s, 1H) 6.12 (s, 1H), 2.11 (s, 1H),
2.04-1.97 (d, J= 12.1Hz, 1H), 1.75-1.72 (m, 2H), 1.58-1.54 (m, 2H), 1.26-1.14 (m, 5H),
1.03 (s, 3H), 1.01 (s, 3H). 13C NMR (CDCl3, 75 MHz): δ 181.4, 180.7, 163.8, 145.0, 143.4,
127.3, 123.2, 121.6, 51.0, 41.5, 40.4, 35.7, 33.5, 32.9, 22.5, 22.5, 18.6.
7-methoxy-2-oxo-2H-chromene-4-carbaldehyde (64). To a solution of 63 (1g,
5.26 mmol) in xylene (25 mL) at 50 ºC was added selenium dioxide (200 mg, 1.8 mmol).
The resulting reaction solution was stirred at 50 ºC under for 24 h. The reaction solution
was quenched with CH2Cl2 and filtered. The organics were collected and concentrated.
The residue was dissolved in CH2Cl2 and flash chromatography (10%-25% EtOAc in
hexanes) afforded product 64 as a yellow solid (0.55 g) in 55% yield. 1H NMR (CDCl3,
400MHz): δ 10.0 (s, 1H), 8.35 (d, Ј= 8.9 Hz, 1H), 7.06 (d, Ј= 8.35 Hz, 1H), 7.02 (d, 1H),
6.96 (s, 1H), 3.85 (s, 3H).

13

C NMR (DMSO, 75 MHz): δ199.3, 168.0, 165.8, 161.3,

148.9, 132.3, 126.7, 118.3, 113.6, 106.5, 61.4.
6a,7,10,10a-tetrahydro-3-methoxy-8-methyl-6-oxo-6H-benzo[c]chromene-10acarbaldehyde (65). To a solution of 64 (0.5 g, 2.4 mmol) in isoprene (10 mL) was added
hydroquinone (25 mg, 0.22 mmol), and the resulting reaction solution was stirred at 50 ºC
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in a sealed tube for 24 h. The reaction solution was extracted and concentrated with
CH2Cl2. Flash chromatographic separation (10-12% EtOAc in hexanes) afforded product
65 as a yellow oil (200 mg) in 31% yield. 1H NMR (CDCl3, 400 MHz): δ 9.50 (s, 1H),
6.90 (s, 1H), 6.68-6.64 (d, 2H), 5.37 (d, 1H), 3.77 (s, 1H), 3.23-3.22 (d, 1H), 2.51-2.43 (m,
2H), 2.33-2.14 (m, 2H), 1.70-1.63 (d, 3H).

13

C NMR (CDCl3, 75 MHz): δ198.0, 197.6,

168.8, 168.7, 160.9, 152.4, 132.3, 130.7, 126.7, 126.5, 118.5, 117.3, 114.1, 111.0, 103.6,
55.8, 50.4, 49.5, 38.5, 37.6, 32.2, 28.0, 27.7, 23.6, 23.3.
(4bS,8aS)-1-bromo-4b,5,6,7,8,8a-hexahydro-4-methoxy-4b,8,8trimethylphenanthren-9(10H)-one. (53). To a solution of 50 (100 mg, 0.28 mmol) in dry
CH3NO2 (20 mL) at 50 ºC was added BF3OEt2 (2.40 mL, 7 equiv), and the resulting
solution was stirred under N2 for 4 h. The reaction solution was diluted with saturated
NaHCO3 (150 mL) and extracted with CH2Cl2 (150 mL x 3). The organic layers were
collected, washed with brine, dried with MgSO4 and concentrated. Flash chromatographic
separation (5-10% EtOAc in hexanes) afforded compound 53 as colorless oil (32 mg) in
53-57% yield. 1H NMR (CDCl3, 400 MHz): δ 7.38 (d, Ј= 8.77 Hz, 1H), 6.67 (d, Ј= 8.77
Hz, 1H), 3.78 (s, 3H), 3.68 (s, 1H), 3.29 (s, 1H), 2.61 (s, 1H), 1.73-1.55 (m, 6H), 1.35 (s,
3H), 1.24 (s, 3H), 1.00 (s, 3H).

13

CNMR (CDCl3, 75 MHz): δ209.2, 157.4, 138.6, 133.9,

131.0, 115.8, 112.0, 63.2, 55.6, 49.1, 45.9, 42.4, 37.0, 33.0, 22.2, 20.5, 19.4.
2-(2-bromo-5-methoxyphenyl)-1-(1,3,3-trimethyl-7-oxa-bicyclo[4.1.0]heptan-2yl)ethanone (57). To a solution of 51 (150 mg, 0.42 mmol) in CH2Cl2 (15 mL) at 0 ºC
was added m-chloroperoxybenzoic acid (70-75%, 110 mg). The resulting reaction solution
was stirred at 0 ºC under N2 for 3 h. The reaction solution was quenched with a solution
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of Na2CO3 and extracted with CH2Cl2. Flash chromatography separation (10-20% EtOAc
in hexanes) afforded product 57 as a colorless oil (88 mg) in 45% yield. 1H NMR (CDCl3,
400 MHz): δ 7.43 (d, Ј= 8.77 Hz, 1H), 6.76 (s,1H), 6.67 (d, Ј= 8.77 Hz, 1H), 6.14 (s, 1H),
3.82 (s, 2H), 3.75 (s, 3H), 2.67 (m, 1H), 2.31-2.29 (m, 1H), 2.14 (s, 3H), 1.69-1.54 (m,
4H), 1.28 (s, 3H), 1.24 (s, 3H).

13

C NMR (CDCl3, 75 MHz): δ196.7, 159.2, 136.3, 133.5,

122.9, 117.3, 114.6, 100.4, 63.7, 58.7, 55.6, 51.6, 38.1, 27.2, 25.0, 19.8, 18.9.
(E)-1-(3-methoxyphenyl)-4-methyl-6-(3,3-dimethyloxirane-2-yl)hex-3-ene-2one. (54). To a solution of 40 (200 mg, 0.73 mmol) in dry CH2Cl2 (15 mL) at 0 ºC was
added m-chloroperoxybenzoic acid (70-75%, 60 mg). The resulting reaction solution was
stirred at 0 ºC under N2 for 3 h. The reaction solution was quenched with a solution of
Na2CO3 and extracted with CH2Cl2. Flash chromatography separation (15-25% EtOAc in
hexanes) afforded product 54 as a colorless oil (120 mg) in 56% yield a cis/trans mixture.
1

H NMR (CDCl3, 400 MHz): δ 7.25-7.19 (m, 1H), 6.79-6.73 (m, 3H), 6.11 (s, 1H), 3.77

(s, 3H), 3.65 (s, 2H), 2.63 (t, 1H), 2.67 (m, 1H), 2.28-2.13 (m, 5H), 1.64 (m, 2H), 1.25 (s,
3H), 1.22 (s, 3H).

13

CNMR (CDCl3, 75 MHz): δ198.0, 160.0, 158.9, 136.5, 129.8, 122.9,

122.0, 115.2, 112.5, 63.7, 58.7, 55.4, 51.7, 38.2, 27.2, 24.9, 19.7, 18.9.
2-(2-bromo-5-methoxyphenyl)-1-(2,6,6-trimethylcyclohex-2-enyl)ethanone
(51). To a solution of 50 (150 mg, 0.42 mmol) in dry CH3NO2 (20 mL) at room temp.
was added BF3OEt2 (2.40 mL, 7eq), and the resulting solution was stirred under N2 for 4 h.
The reaction solution was extracted with CH2Cl2 (150 mL x 3). The organic layers were
collected, washed with brine, dried with MgSO4 and concentrated. Flash chromatographic
separation (5-10% EtOAc in hexanes) afforded compound 51 as colorless oil (32 mg) in
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58% yield. 1H NMR (CDCl3, 400 MHz): δ 7.40 (d, Ј= 8.40 Hz, 1H), 6.70 (s,1H), 6.67 (d,
Ј= 8.40 Hz, 1H), 5.58 (s, 1H), 4.02-3.90 (q, J= 16.0 Hz, 2H), 3.75 (s, 3H), 2.92 (s, 1H),
2.09-2.08 (m, 2H), 1.79-1.77 (m, 2H), 1.55 (s, 3H), 1.17 (s, 1H), 1.00 (s, 3H), 0.96 (s, 3H).
13

C NMR (CDCl3, 75 MHz): δ 208.9, 159.0, 135.1, 133.5, 130.1, 124.1, 117.3, 115.9,

114.7, 62.7, 55.6, 53.0, 33.0, 30.7, 28.4, 27.9, 23.7, 22.9.
DNA Oxidative Damage of QMs and Catechol Precursors 1, 22-26 in the
presence of CuCl2. The 30 mer oligonucleotide of the DNA target was radiolabeled with
32P-phosphate at the 5’-position by T4 polynucleotide kinase (New England Biolabs, MA)
according to the manufacturer’s instructions. Hybridization of complementary strands was
achieved by heating a solution of oligonucleotides (0.5 µM each, 0.28 µCi/µl) in a 90 ºC
water bath and then cooling to room temperature slowly. A series of reaction solutions
containing compounds 1, 22-26 were prepared, and the DNA lesion was initiated by the
addition of the catechols. The final reaction solutions (10 µl each) contained 25 µM
duplex DNA (0.07 µCi/µl), 10 mM phosphate buffer (pH 7.0), 1 mM MgCl2, CuCl2 (40
µM) compounds 1, 22-26 (0, 10, 20, 30, and 40 µM, respectively), and 10% acetonitrile.
The resulting reaction solutions were incubated at 37 ºC for 12 h. A portion of the reaction
solutions (0.1 µCi) was mixed with formaldehyde and directly separated by a 20%
denatured PAGE for the investigation of direct DNA cleavage. The piperdine treatment
was achieved by mixing the reaction solutions with a 10% piperdine in water (100 µl) and
then heating at 90 ºC for 20 min. The resulting solutions were lypholized, and the residues
were dissolved in 90% formamide loading buffer. Each reaction solution (0.15 µCi) was
separated by 20% denatured PAGE and analyzed by gel image analysis software. The
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percentage of DNA damage was calculated based on the amount of the originally
radiolabeled DNA band versus the total amount of radioactive DNA using the quantitative
analysis software provided by the imager manufacturer.
DNA Oxidative Damage of Diterpenone Catechols 1, 22-26 in the presence of
CuCl2 and NADH. A series of reaction solutions containing compounds 1, 22-26 were
prepared similarly as described above. The duplex DNA solution was mixed with a
solution of CuCl2 and NADH first, and then followed by the addition of catechol solutions.
The final reaction solutions (20 µl each) contained 0.25µM duplex DNA (0.07 µCi/µl),
10mM phosphate buffer (pH 7.0), 1 mM MgCl2, 100 µM NADH, CuCl2 (5 µM),
compounds 1, 22-26 (0,0.5,1,2, and 5 µM, respectively), and 5% acetonitrile. The
resulting reaction solutions were incubated at 37 ºC for 6 h. The piperdine treatment and
subsequent PAGE separation were carried out similarly as described above. All the
experiments were repeated at least three times independently.
DNA Oxidative Damage by free radicals using Fe3+-EDTA and H2O2 The
Fenton reactions were carried out according to the published protocol in DNA assays
comprehensive volume I and similar to described above. The investigation of the effect by
radical scavengers and copper chelators on the DNA damage with terpenone 1 and Cu2+
was carried out similarly as described above. The final concentrations for compound 1
were 10-40 µM and CuCl2 40 µM. The concentrations of radical scavengers and chelators
used were 5% for ethanol, 0.1M for mannitol, 0.1M for sodium formate, 5% for DMSO,
1.5 unit/10 µl for catalase, 50 µM for bathocuproine, and 0.1M for methional, respectively.
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The piperdine treatment was carried out after incubating the reaction mixtures at 37 ºC for
10 h. All the experiments were repeated at least three times independently.

Spectroscopic Analysis
ROESY NMR was used to confirm the para position of the bromide atom in compound 48
with regard to the methoxy group (Figure 5.3). This experiment is useful because it is used
to determine which signals arise from protons that are close to each other in space even if
they are not bonded. The ROESY spectrum showed that the proton Ha at 7.45 ppm and
proton Hc at 6.85 ppm correlated, which is the chemical shift region for the aromatic
hydrogens. Proton Hc also correlated with the methoxy protons Hd located at 3.85 ppm and
these hydrogens are correlated with proton Hb at 6.97 ppm which is subsequently
correlated to the benzylic protons Hd at 4.32 ppm. The para position with respect to the
methoxy group is therefore deduced using the data from the ROESY NMR spectra and 1H
NMR splitting patterns.
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1

H and 13C NMR spectra.
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ROESY spectrum of compound 48 showing crosspeaks confirming the para position of the bromide
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